Interleukin	B-protein
4	I-protein
activates	O
a	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	B-protein
(	I-protein
Stat	I-protein
)	I-protein
protein	I-protein
which	O
interacts	O
with	O
an	O
interferon-gamma	B-DNA
activation	I-DNA
site-like	I-DNA
sequence	I-DNA
upstream	O
of	O
the	O
I	B-DNA
epsilon	I-DNA
exon	I-DNA
in	O
a	O
human	B-cell_line
B	I-cell_line
cell	I-cell_line
line	I-cell_line
.	O

Evidence	O
for	O
the	O
involvement	O
of	O
Janus	B-protein
kinase	I-protein
3	I-protein
and	O
interleukin-4	B-protein
Stat	I-protein
.	O

Germ	B-RNA
line	I-RNA
C	I-RNA
transcripts	I-RNA
can	O
be	O
induced	O
by	O
IL-4	B-protein
in	O
the	O
human	B-cell_line
B	I-cell_line
cell	I-cell_line
line	I-cell_line
,	O
BL-2	B-cell_line
.	O

Utilizing	O
a	O
IFN-gamma	B-DNA
activation	I-DNA
site-like	I-DNA
DNA	I-DNA
sequence	I-DNA
element	I-DNA
located	O
upstream	O
of	O
the	O
I	B-DNA
epsilon	I-DNA
exon	I-DNA
,	O
we	O
demonstrated	O
by	O
gel	O
mobility	O
shift	O
assays	O
that	O
IL-4	B-protein
induced	O
a	O
binding	O
activity	O
in	O
the	O
cytosol	O
and	O
nucleus	O
of	O
BL-2	B-cell_line
cells	I-cell_line
.	O

This	O
factor	O
was	O
designated	O
IL-4	B-protein
NAF	I-protein
(	O
IL-4-induced	B-protein
nuclear-activating	I-protein
factors	I-protein
)	O
and	O
was	O
identified	O
as	O
a	O
tyrosine	B-protein
phosphoprotein	I-protein
,	O
which	O
translocates	O
from	O
the	O
cytosol	O
to	O
the	O
nucleus	O
upon	O
IL-4	B-protein
treatment	O
.	O

Because	O
these	O
are	O
the	O
characteristics	O
of	O
a	O
signal	B-protein
transducer	I-protein
and	I-protein
activator	I-protein
of	I-protein
transcription	I-protein
(	I-protein
Stat	I-protein
)	I-protein
protein	I-protein
,	O
we	O
determined	O
whether	O
antibodies	B-protein
to	I-protein
Stat	I-protein
proteins	I-protein
will	O
interfere	O
with	O
gel	O
mobility	O
shift	O
and	O
found	O
that	O
antibodies	B-protein
to	I-protein
IL-4	I-protein
Stat	I-protein
,	O
also	O
known	O
as	O
Stat6	B-protein
,	O
but	O
not	O
antibodies	B-protein
to	O
other	O
Stat	B-protein
proteins	I-protein
,	O
interfere	O
with	O
the	O
formation	O
of	O
the	O
IL-4	B-protein
NAF	I-protein
complex	I-protein
.	O

Congruous	O
with	O
the	O
involvement	O
of	O
a	O
Stat	B-protein
protein	I-protein
,	O
IL-4	B-protein
induced	O
robust	O
Janus	B-protein
kinase	I-protein
3	I-protein
(	O
JAK3	B-protein
)	O
activity	O
in	O
BL-2	B-cell_line
cells	I-cell_line
.	O

Cotransfection	O
of	O
JAK3	B-protein
with	O
IL-4	B-protein
Stat	I-protein
into	O
COS-7	B-cell_line
cells	I-cell_line
produced	O
an	O
intracellular	O
activity	O
which	O
bound	O
the	O
same	O
IFN-gamma	B-DNA
activation	I-DNA
site-like	I-DNA
sequence	I-DNA
and	O
comigrated	O
with	O
IL-4	B-protein
NAF	I-protein
in	O
electrophoretic	O
mobility	O
shift	O
assay	O
.	O

These	O
results	O
show	O
that	O
IL-4	B-protein
NAF	I-protein
is	O
IL-4	B-protein
Stat	I-protein
,	O
which	O
is	O
activated	O
by	O
JAK3	B-protein
in	O
response	O
to	O
IL-4	B-protein
receptor	O
engagement	O
.	O

Interleukin	NULL
4	NULL
Activates	NULL
a	NULL
Signal	NULL
Transducer	NULL
and	NULL
Activator	NULL
of	NULL
Transcription	NULL
(	NULL
Stat	NULL
)	NULL
Protein	NULL
which	NULL
Interacts	NULL
with	NULL
an	NULL
Interferon-y	NULL
Activation	NULL
Site-like	NULL
Sequence	NULL
Upstream	NULL
of	NULL
the	NULL
I	NULL
,	NULL
Exon	NULL
in	NULL
a	NULL
Human	NULL
B	NULL
Cell	NULL
Line	NULL
Evidence	NULL
for	NULL
the	NULL
Involvement	NULL
of	NULL
Janus	NULL
Kinase	NULL
3	NULL
and	NULL
Interleukin-4	NULL
Stat	NULL
Xu	NULL
Fenghao	NULL
,	NULL
*	NULL
Andrew	NULL
Saxon	NULL
,	NULL
**	NULL
Andrew	NULL
Nguyen	NULL
,	NULL
*	NULL
Zhang	NULL
Ke	NULL
,	NULL
*	NULL
David	NULL
Diaz-Sanchez	NULL
,	NULL
*	NULL
and	NULL
André	NULL
Nel**	NULL
*The	NULL
Hart	NULL
and	NULL
Louise	NULL
Lyon	NULL
Laboratory	NULL
,	NULL
Division	NULL
of	NULL
Clinical	NULL
Immunology	NULL
and	NULL
Allergy	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
*The	NULL
Molecular	NULL
Biology	NULL
Institute	NULL
,	NULL
and	NULL
'The	NULL
Jonsson	NULL
Comprehensive	NULL
Cancer	NULL
Center	NULL
,	NULL
UCLA	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
California	NULL
90024-1680	NULL
Abstract	NULL
Germ	NULL
line	NULL
C.	NULL
transcripts	NULL
can	NULL
be	NULL
induced	NULL
by	NULL
IL-4	NULL
in	NULL
the	NULL
human	NULL
B	NULL
cell	NULL
line	NULL
,	NULL
BL-2	NULL
.	NULL

Utilizing	NULL
a	NULL
IFN-y	NULL
activation	NULL
site-like	NULL
DNA	NULL
sequence	NULL
element	NULL
located	NULL
upstream	NULL
of	NULL
the	NULL
I	NULL
,	NULL
exon	NULL
,	NULL
we	NULL
demonstrated	NULL
by	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
that	NULL
IL-4	NULL
induced	NULL
a	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
cytosol	NULL
and	NULL
nucleus	NULL
of	NULL
BL-2	NULL
cells	NULL
.	NULL

This	NULL
factor	NULL
was	NULL
designated	NULL
IL-4	NULL
NAF	NULL
(	NULL
IL-4-induced	NULL
nuclear-activating	NULL
factors	NULL
)	NULL
and	NULL
was	NULL
identified	NULL
as	NULL
a	NULL
tyrosine	NULL
phosphoprotein	NULL
,	NULL
which	NULL
translocates	NULL
from	NULL
the	NULL
cytosol	NULL
to	NULL
the	NULL
nucleus	NULL
upon	NULL
IL-4	NULL
treatment	NULL
.	NULL

Because	NULL
these	NULL
are	NULL
the	NULL
characteristics	NULL
of	NULL
a	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
(	NULL
Stat	NULL
)	NULL
protein	NULL
,	NULL
we	NULL
determined	NULL
whether	NULL
antibodies	NULL
to	NULL
Stat	NULL
proteins	NULL
will	NULL
interfere	NULL
with	NULL
gel	NULL
mobility	NULL
shift	NULL
and	NULL
found	NULL
that	NULL
antibodies	NULL
to	NULL
IL-4	NULL
Stat	NULL
,	NULL
also	NULL
known	NULL
as	NULL
Stat6	NULL
,	NULL
but	NULL
not	NULL
antibodies	NULL
to	NULL
other	NULL
Stat	NULL
proteins	NULL
,	NULL
interfere	NULL
with	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
IL-4	NULL
NAF	NULL
complex	NULL
.	NULL

Congruous	NULL
with	NULL
the	NULL
involvement	NULL
of	NULL
a	NULL
Stat	NULL
protein	NULL
,	NULL
IL-4	NULL
induced	NULL
robust	NULL
Janus	NULL
kinase	NULL
3	NULL
(	NULL
JAK3	NULL
)	NULL
activity	NULL
in	NULL
BL-2	NULL
cells	NULL
.	NULL

Cotransfection	NULL
of	NULL
JAK3	NULL
with	NULL
IL-4	NULL
Stat	NULL
into	NULL
COS-7	NULL
cells	NULL
produced	NULL
an	NULL
intracellular	NULL
activity	NULL
which	NULL
bound	NULL
the	NULL
same	NULL
IFN-y	NULL
activation	NULL
site-like	NULL
sequence	NULL
and	NULL
comigrated	NULL
with	NULL
IL-4	NULL
NAF	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
IL-4	NULL
NAF	NULL
is	NULL
IL-4	NULL
Stat	NULL
,	NULL
which	NULL
is	NULL
activated	NULL
by	NULL
JAK3	NULL
in	NULL
response	NULL
to	NULL
IL-4	NULL
receptor	NULL
engage-ment	NULL
.	NULL

(	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

1995	NULL
.	NULL

96:907-914	NULL
.	NULL
)	NULL

Key	NULL
words	NULL
:	NULL
interleukin-4-induced	NULL
nuclear-activating	NULL
factor	NULL
«	NULL
germline	NULL
Immunoglobulin	NULL
E	NULL
«	NULL
transcription	NULL
+	NULL
signaling	NULL
Introduction	NULL
IL-4	NULL
exerts	NULL
pleiotropic	NULL
effects	NULL
on	NULL
the	NULL
function	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
including	NULL
lymphocytes	NULL
,	NULL
macrophages	NULL
,	NULL
fibroblasts	NULL
,	NULL
and	NULL
endothelial	NULL
cells	NULL
(	NULL
1	NULL
)	NULL
.	NULL

In	NULL
B	NULL
cells	NULL
,	NULL
IL-4	NULL
is	NULL
involved	NULL
in	NULL
cell	NULL
proliferation	NULL
and	NULL
differentiation	NULL
.	NULL

Among	NULL
the	NULL
differentiation	NULL
effects	NULL
are	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
MHC-II	NULL
and	NULL
CD23	NULL
(	NULL
Fc.R	NULL
;	NULL
p	NULL
,	NULL
)	NULL
gene	NULL
products	NULL
,	NULL
as	NULL
well	NULL
as	NULL
Ig	NULL
heavy	NULL
chain	NULL
class	NULL
switching	NULL
to	NULL
IgG1	NULL
and	NULL
Address	NULL
correspondence	NULL
to	NULL
André	NULL
Nel	NULL
,	NULL
Division	NULL
of	NULL
Clinical	NULL
Immunology	NULL
and	NULL
Allergy	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
52-175	NULL
Center	NULL
for	NULL
Health	NULL
Sci-ences	NULL
,	NULL
10833	NULL
Le	NULL
Conte	NULL
Avenue	NULL
,	NULL
UCLA	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
90024-1680	NULL
.	NULL

Phone:310-825-6620	NULL
;	NULL
FAX:310-206-8107	NULL
.	NULL

Received	NULL
for	NULL
publication	NULL
10	NULL
January	NULL
1995	NULL
and	NULL
accepted	NULL
in	NULL
revised	NULL
form	NULL
28	NULL
April	NULL
1995	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

©	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Clinical	NULL
Investigation	NULL
,	NULL
Inc.	NULL
0021-9738/95/08/0907/08	NULL
$	NULL
2.00	NULL
Volume	NULL
96	NULL
,	NULL
August	NULL
1995	NULL
,	NULL
907-914	NULL
IgE	NULL
(	NULL
2-5	NULL
)	NULL
.	NULL

While	NULL
induction	NULL
of	NULL
proliferation	NULL
appears	NULL
to	NULL
involve	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
substrate	NULL
,	NULL
4PS/IRS-1	NULL
,	NULL
and	NULL
recruitment	NULL
of	NULL
the	NULL
second	NULL
messengers	NULL
phosphoinositide	NULL
3-kinase	NULL
(	NULL
PI-3	NULL
kinase	NULL
)	NULL
and	NULL
Grb2	NULL
,	NULL
not	NULL
much	NULL
is	NULL
known	NULL
about	NULL
the	NULL
pathways	NULL
by	NULL
which	NULL
IL-4	NULL
directs	NULL
cellular	NULL
differentiation	NULL
(	NULL
6-9	NULL
)	NULL
.	NULL

IgE	NULL
isotype	NULL
switching	NULL
involves	NULL
the	NULL
sequential	NULL
steps	NULL
of	NULL
germline	NULL
transcription	NULL
followed	NULL
by	NULL
heavy	NULL
chain	NULL
gene	NULL
rearrangement	NULL
(	NULL
4	NULL
,	NULL
5	NULL
,	NULL
10	NULL
)	NULL
.	NULL

IL-4	NULL
induces	NULL
germline	NULL
transcription	NULL
(	NULL
4	NULL
,	NULL
5	NULL
,	NULL
10	NULL
)	NULL
,	NULL
while	NULL
IFN-y	NULL
inhibits	NULL
the	NULL
process	NULL
(	NULL
11	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
if	NULL
IFN-y	NULL
and	NULL
IL4	NULL
have	NULL
either	NULL
antagonistic	NULL
or	NULL
analogous	NULL
effects	NULL
on	NULL
transcription	NULL
,	NULL
an	NULL
IL-4	NULL
induced	NULL
DNA	NULL
binding	NULL
factor	NULL
which	NULL
reacts	NULL
with	NULL
an	NULL
IFN-y	NULL
response	NULL
element	NULL
(	NULL
also	NULL
known	NULL
as	NULL
an	NULL
IFN-y	NULL
activation	NULL
site	NULL
or	NULL
GAS	NULL
'	NULL
)	NULL
,	NULL
was	NULL
demonstrated	NULL
to	NULL
be	NULL
present	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
in	NULL
the	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
,	NULL
Thp-1	NULL
(	NULL
12	NULL
)	NULL
.	NULL

This	NULL
factor	NULL
,	NULL
which	NULL
interacts	NULL
with	NULL
an	NULL
upstream	NULL
sequence	NULL
in	NULL
the	NULL
FcyR	NULL
,	NULL
gene	NULL
,	NULL
was	NULL
named	NULL
IL-4-induced	NULL
nuclear-activating	NULL
factor	NULL
(	NULL
IL-4	NULL
NAF	NULL
)	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
;	NULL
12	NULL
)	NULL
.	NULL

A	NULL
homologous	NULL
9-bp	NULL
sequence	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
CD23	NULL
gene	NULL
was	NULL
described	NULL
by	NULL
Kohler	NULL
and	NULL
Rieber	NULL
and	NULL
designated	NULL
IL-4	NULL
nuclear-activated	NULL
factor	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
;	NULL
13	NULL
)	NULL
.	NULL

In	NULL
murine	NULL
B	NULL
cells	NULL
,	NULL
an	NULL
IL-4-inducible	NULL
factor	NULL
which	NULL
interacts	NULL
with	NULL
the	NULL
initiation	NULL
site	NULL
of	NULL
the	NULL
germline	NULL
I	NULL
,	NULL
exon	NULL
,	NULL
was	NULL
designated	NULL
signal-transducing	NULL
factor	NULL
of	NULL
IL-4	NULL
(	NULL
STF-IL4	NULL
)	NULL
by	NULL
Schindler	NULL
et	NULL
al	NULL
.	NULL

(	NULL
14	NULL
)	NULL
.	NULL

Utilizing	NULL
the	NULL
Fc	NULL
.	NULL

,	NULL
R	NULL
,	NULL
probe	NULL
to	NULL
purify	NULL
an	NULL
interactive	NULL
Thp-1	NULL
cell	NULL
protein	NULL
,	NULL
Hou	NULL
et	NULL
al	NULL
.	NULL

have	NULL
recently	NULL
cloned	NULL
an	NULL
IL-4-induced	NULL
DNA	NULL
binding	NULL
factor	NULL
which	NULL
they	NULL
designated	NULL
the	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
by	NULL
IL-4	NULL
(	NULL
IL-4	NULL
Stat	NULL
)	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Stat	NULL
proteins	NULL
are	NULL
a	NULL
novel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
which	NULL
,	NULL
after	NULL
phosphorylation	NULL
and	NULL
homo-	NULL
or	NULL
heterodimeri-zation	NULL
in	NULL
the	NULL
cytosol	NULL
,	NULL
shuttle	NULL
to	NULL
the	NULL
nucleus	NULL
where	NULL
they	NULL
interact	NULL
with	NULL
select	NULL
promoter	NULL
sequences	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Although	NULL
not	NULL
proven	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
IL-4	NULL
NAF	NULL
represents	NULL
a	NULL
homo-	NULL
or	NULL
heterodimerized	NULL
version	NULL
of	NULL
IL-4	NULL
Stat	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
IL-4	NULL
Stat	NULL
,	NULL
several	NULL
of	NULL
the	NULL
Stat	NULL
genes	NULL
have	NULL
now	NULL
been	NULL
cloned	NULL
,	NULL
including	NULL
}	NULL
(	NULL
p91/p84	NULL
)	NULL
,	NULL
Stat2	NULL
(	NULL
p113	NULL
)	NULL
,	NULL
Stat3	NULL
(	NULL
p89	NULL
,	NULL
acute	NULL
phase	NULL
response	NULL
factor	NULL
,	NULL
APRF	NULL
)	NULL
,	NULL
Stat4	NULL
(	NULL
p88	NULL
)	NULL
,	NULL
and	NULL
Stats	NULL
(	NULL
p90	NULL
,	NULL
mammary	NULL
gland	NULL
factor	NULL
,	NULL
MGF	NULL
)	NULL
(	NULL
18-21	NULL
)	NULL
.	NULL

It	NULL
would	NULL
appear	NULL
as	NULL
if	NULL
the	NULL
connection	NULL
between	NULL
Stat	NULL
proteins	NULL
and	NULL
a	NULL
variety	NULL
of	NULL
activating	NULL
receptors	NULL
is	NULL
based	NULL
on	NULL
the	NULL
use	NULL
of	NULL
a	NULL
novel	NULL
family	NULL
of	NULL
tyrosine	NULL
protein	NULL
kinases	NULL
also	NULL
known	NULL
as	NULL
Janus	NULL
kinase	NULL
(	NULL
JAK	NULL
)	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
there	NULL
appears	NULL
to	NULL
be	NULL
selectivity	NULL
in	NULL
the	NULL
use	NULL
of	NULL
JAK	NULL
's	NULL
and	NULL
Stat	NULL
proteins	NULL
by	NULL
specific	NULL
receptors	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
IFN-a	NULL
utilizes	NULL
JAK1	NULL
and	NULL
Tyk2	NULL
to	NULL
activate	NULL
Statl	NULL
and	NULL
1	NULL
.	NULL

Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
APRE	NULL
,	NULL
acute	NULL
phase	NULL
response	NULL
ele-ment	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
GAS	NULL
,	NULL
IFN-y	NULL
activation	NULL
site	NULL
;	NULL
IL-4	NULL
NAF	NULL
,	NULL
IL-4-induced	NULL
nuclear	NULL
activating	NULL
factor	NULL
;	NULL
JAK	NULL
,	NULL
Janus	NULL
kinase	NULL
;	NULL
PTK	NULL
,	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
;	NULL
Stat	NULL
,	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
.	NULL

Interleukin	NULL
4	NULL
Activates	NULL
a	NULL
Stat	NULL
Protein	NULL
which	NULL
Interacts	NULL
with	NULL
the	NULL
I	NULL
,	NULL
Promoter	NULL
907	NULL
Stat2	NULL
,	NULL
while	NULL
IFN-y	NULL
utilizes	NULL
JAK1	NULL
and	NULL
JAK2	NULL
to	NULL
activate	NULL
Statl	NULL
(	NULL
16	NULL
,	NULL
17	NULL
,	NULL
22	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
was	NULL
reported	NULL
that	NULL
IL-2	NULL
and	NULL
IL-4	NULL
activate	NULL
JAK3	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
and	NULL
NK	NULL
cells	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
;	NULL
the	NULL
homologous	NULL
use	NULL
of	NULL
JAK3	NULL
by	NULL
these	NULL
two	NULL
cytokine	NULL
receptors	NULL
is	NULL
attributed	NULL
to	NULL
their	NULL
sharing	NULL
of	NULL
a	NULL
common	NULL
y	NULL
(	NULL
Cy	NULL
)	NULL
subunit	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
it	NULL
appears	NULL
as	NULL
if	NULL
JAK3	NULL
interacts	NULL
directly	NULL
with	NULL
Cy	NULL
and	NULL
that	NULL
JAK3	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
signaling	NULL
by	NULL
the	NULL
IL-4	NULL
receptor	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
with	NULL
the	NULL
fact	NULL
that	NULL
IL-4	NULL
NAF	NULL
and	NULL
STF-IL-4	NULL
are	NULL
known	NULL
to	NULL
be	NULL
tyrosine	NULL
phosphoproteins	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
they	NULL
are	NULL
JAK3	NULL
substrates	NULL
(	NULL
12	NULL
,	NULL
14	NULL
)	NULL
.	NULL

We	NULL
chose	NULL
a	NULL
GAS-like	NULL
element	NULL
upstream	NULL
of	NULL
the	NULL
human	NULL
I	NULL
,	NULL
exon	NULL
as	NULL
an	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
probe	NULL
to	NULL
demonstrate	NULL
induction	NULL
of	NULL
a	NULL
binding	NULL
factor	NULL
,	NULL
designated	NULL
IL-4	NULL
NAF	NULL
,	NULL
in	NULL
a	NULL
human	NULL
B	NULL
cell	NULL
line	NULL
which	NULL
undergoes	NULL
germline	NULL
C	NULL
,	NULL
transcription	NULL
.	NULL

This	NULL
protein	NULL
is	NULL
a	NULL
tyrosine	NULL
phosphoprotein	NULL
which	NULL
translocates	NULL
from	NULL
the	NULL
cytosol	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
and	NULL
which	NULL
comigrates	NULL
during	NULL
EMSA	NULL
with	NULL
IL-4	NULL
Stat	NULL
which	NULL
has	NULL
been	NULL
activated	NULL
in	NULL
COS-7	NULL
cells	NULL
by	NULL
cotransfection	NULL
of	NULL
JAK3	NULL
.	NULL

Methods	NULL
Materials	NULL
.	NULL

Monoclonal	NULL
antiphosphotyrosine	NULL
antiserum	NULL
(	NULL
4G10	NULL
)	NULL
and	NULL
polyclonal	NULL
anti-JAK1	NULL
were	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
Inc.	NULL
(	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Antibodies	NULL
recognizing	NULL
Stat	NULL
1	NULL
(	NULL
p91	NULL
)	NULL
and	NULL
Stat	NULL
3	NULL
(	NULL
p89	NULL
)	NULL
were	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
Chris	NULL
Schindler	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Columbia	NULL
University	NULL
,	NULL
New	NULL
York	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Culture	NULL
media	NULL
components	NULL
were	NULL
from	NULL
HyClone	NULL
Laboratories	NULL
(	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
and	NULL
M.A	NULL
.	NULL

Bioproducts	NULL
(	NULL
Walk-erswille	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

[	NULL
a	NULL
``	NULL
P	NULL
]	NULL
dCTP	NULL
were	NULL
from	NULL
ICN	NULL
Biomedicals	NULL
Inc.	NULL
(	NULL
Costa	NULL
Mesa	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Double-strand	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
was	NULL
from	NULL
Pharmacia	NULL
LKB	NULL
Biotechnology	NULL
Inc.	NULL
(	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

Salmon	NULL
sperm	NULL
DNA	NULL
and	NULL
Klenow	NULL
fragment	NULL
were	NULL
from	NULL
Stratagene	NULL
Inc.	NULL
(	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Human	NULL
recombinant	NULL
IL-4	NULL
and	NULL
IL-6	NULL
were	NULL
from	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
(	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
.	NULL

Plasmid	NULL
Maxiprep	NULL
kit	NULL
was	NULL
from	NULL
Promega	NULL
Corp.	NULL
(	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

pcDNA3	NULL
expression	NULL
vector	NULL
was	NULL
from	NULL
Invitrogen	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
tyrosine	NULL
phosphatase	NULL
,	NULL
PTP-1C	NULL
,	NULL
was	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
Nick	NULL
Tonks	NULL
(	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Anti-JAK3	NULL
antiserum	NULL
and	NULL
JAK3	NULL
cDNA	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
John	NULL
J.	NULL
O'Shea	NULL
(	NULL
Laboratory	NULL
of	NULL
Experimental	NULL
Immunology	NULL
,	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
Frederick	NULL
,	NULL
MD	NULL
;	NULL
23	NULL
)	NULL
.	NULL

IL-4	NULL
Stat	NULL
cDNA	NULL
and	NULL
rabbit	NULL
antiserum	NULL
to	NULL
its	NULL
protein	NULL
product	NULL
were	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
Steven	NULL
L.	NULL
McKnight	NULL
(	NULL
Tularik	NULL
Inc.	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
;	NULL
15	NULL
)	NULL
.	NULL

The	NULL
human	NULL
BL-2	NULL
cell	NULL
line	NULL
was	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
Jan	NULL
de	NULL
Vries	NULL
(	NULL
DNAX	NULL
Research	NULL
Institute	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
;	NULL
28	NULL
)	NULL
.	NULL

This	NULL
cell	NULL
line	NULL
produces	NULL
IgM	NULL
and	NULL
expresses	NULL
germline	NULL
C	NULL
,	NULL
in	NULL
response	NULL
to	NULL
IL-4	NULL
treatment	NULL
.	NULL

COS-7	NULL
cells	NULL
were	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
Owen	NULL
Witte	NULL
(	NULL
HHMI	NULL
,	NULL
UCLA	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

All	NULL
other	NULL
materials	NULL
were	NULL
of	NULL
the	NULL
highest	NULL
purity	NULL
grade	NULL
available	NULL
and	NULL
were	NULL
obtained	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

Cell	NULL
culture	NULL
.	NULL

BL-2	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI-1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
50	NULL
U/ml	NULL
penicillin	NULL
and	NULL
50	NULL
U/ml	NULL
streptomycin	NULL
(	NULL
complete	NULL
medium	NULL
)	NULL
.	NULL

COS-7	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
DME	NULL
,	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
and	NULL
100	NULL
U	NULL
each	NULL
of	NULL
penicillin	NULL
and	NULL
streptomycin	NULL
.	NULL

Cellular	NULL
stimulation	NULL
and	NULL
extraction	NULL
.	NULL

Whole	NULL
cell	NULL
extraction	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
by	NULL
Wegenka	NULL
et	NULL
al	NULL
.	NULL

(	NULL
29	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
in	NULL
500	NULL
ul	NULL
complete	NULL
medium	NULL
were	NULL
either	NULL
mock-treated	NULL
or	NULL
treated	NULL
with	NULL
20	NULL
ng/ml	NULL
IL-4	NULL
,	NULL
100	NULL
U/ml	NULL
IL-6	NULL
,	NULL
100	NULL
U/ml	NULL
IL-2	NULL
or	NULL
100	NULL
ng/ml	NULL
PMA	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
periods	NULL
at	NULL
37°C	NULL
.	NULL

Cells	NULL
pellets	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
ice-cold	NULL
PBS	NULL
and	NULL
then	NULL
lysed	NULL
in	NULL
50	NULL
mM	NULL
Tris/HCl	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
10	NULL
mM	NULL
3-	NULL
(	NULL
3-cholamidopropyl	NULL
)	NULL
-dimethyl-ammonio	NULL
)	NULL
-1-propanesulfonate-	NULL
(	NULL
CHAPS	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
,	NULL
100	NULL
uM	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
5	NULL
mM	NULL
NaF	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
750	NULL
mM	NULL
PMSF	NULL
,	NULL
10	NULL
ug/ml	NULL
each	NULL
of	NULL
aprotinin	NULL
,	NULL
pepstatin	NULL
,	NULL
and	NULL
leupeptin	NULL
.	NULL

After	NULL
20	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
insoluble	NULL
material	NULL
was	NULL
removed	NULL
at	NULL
14,000	NULL
g	NULL
for	NULL
5	NULL
min	NULL
in	NULL
a	NULL
microcentrifuge	NULL
.	NULL

Cytosolic	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
with	NULL
minor	NULL
modifications	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
5	NULL
x	NULL
10	NULL
'	NULL
BL-2	NULL
cells	NULL
were	NULL
lysed	NULL
by	NULL
freeze-thawing	NULL
in	NULL
100	NULL
Ll	NULL
hypotonic	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Hepes	NULL
,	NULL
908	NULL
Fenghao	NULL
et	NULL
al	NULL
.	NULL

pH	NULL
7.9	NULL
,	NULL
1.5	NULL
mM	NULL
MgC1	NULL
;	NULL
,	NULL
0.2	NULL
mM	NULL
PMSF	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
DTT	NULL
)	NULL
.	NULL

After	NULL
three	NULL
additional	NULL
freeze	NULL
and	NULL
thaw	NULL
cycles	NULL
,	NULL
the	NULL
lysates	NULL
were	NULL
neutralized	NULL
with	NULL
100	NULL
ul	NULL
2	NULL
%	NULL
cytosolic	NULL
buffer	NULL
(	NULL
30	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
40	NULL
%	NULL
glycerol	NULL
,	NULL
190	NULL
mM	NULL
KC1	NULL
,	NULL
0.4	NULL
mM	NULL
EDTA	NULL
,	NULL
0.2	NULL
mM	NULL
PMSF	NULL
,	NULL
0.4	NULL
mM	NULL
DTT	NULL
,	NULL
2	NULL
mM	NULL
NaF	NULL
,	NULL
0.2	NULL
mM	NULL
Na	NULL
;	NULL
VO	NULL
,	NULL
,	NULL
1	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
and	NULL
1	NULL
pg/ml	NULL
aprotinin	NULL
)	NULL
and	NULL
spun	NULL
through	NULL
a	NULL
40	NULL
%	NULL
sucrose	NULL
cushion	NULL
for	NULL
10	NULL
min	NULL
at	NULL
3,000	NULL
g	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
transferred	NULL
into	NULL
a	NULL
fresh	NULL
tube	NULL
and	NULL
respun	NULL
at	NULL
14,000	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
kept	NULL
as	NULL
cytosolic	NULL
extracts	NULL
.	NULL

The	NULL
nuclear	NULL
pellet	NULL
was	NULL
transferred	NULL
to	NULL
fresh	NULL
tubes	NULL
and	NULL
extracted	NULL
by	NULL
vortexing	NULL
in	NULL
25	NULL
ul	NULL
nuclear	NULL
extraction	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
240	NULL
mM	NULL
KCI	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.1	NULL
mM	NULL
PMSF	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
and	NULL
0.1	NULL
%	NULL
NP-40	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
spun	NULL
at	NULL
14,000	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
and	NULL
the	NULL
supernatants	NULL
were	NULL
collected	NULL
as	NULL
nuclear	NULL
extracts	NULL
.	NULL

Performance	NULL
of	NULL
EMSA	NULL
.	NULL

Double-stranded	NULL
oligonucleotide	NULL
probes	NULL
used	NULL
in	NULL
the	NULL
EMSA	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
The	NULL
GAS-like	NULL
sequence	NULL
upstream	NULL
of	NULL
the	NULL
human	NULL
I	NULL
,	NULL
exon	NULL
(	NULL
S1	NULL
oligonucleotide	NULL
)	NULL
:	NULL
5-GACTTCCCAAGA-ACAG-3	NULL
'	NULL
(	NULL
31	NULL
)	NULL
;	NULL
IL-6	NULL
acute	NULL
phrase	NULL
response	NULL
element	NULL
(	NULL
APRE	NULL
)	NULL
in	NULL
the	NULL
;	NULL
-macroglobulin	NULL
promoter	NULL
:	NULL
5-GATCCTTCTGGGAATTCCTA-3	NULL
'	NULL
(	NULL
32	NULL
)	NULL
;	NULL
IL-6	NULL
response	NULL
element	NULL
in	NULL
the	NULL
c-jun	NULL
promoter	NULL
(	NULL
JRE-IL6	NULL
)	NULL
,	NULL
5-GCGCTT-CCGACAGTGACGCGAGCCG-3	NULL
'	NULL
(	NULL
33	NULL
)	NULL
.	NULL

The	NULL
complementary	NULL
oligonucleotide	NULL
was	NULL
annealed	NULL
and	NULL
end-labeled	NULL
with	NULL
(	NULL
P	NULL
]	NULL
dCTP	NULL
.	NULL

8	NULL
ul	NULL
(	NULL
5-10	NULL
ug	NULL
)	NULL
of	NULL
cytosolic	NULL
,	NULL
nuclear	NULL
or	NULL
whole	NULL
cell	NULL
extract	NULL
were	NULL
incubated	NULL
with	NULL
10	NULL
ml	NULL
2	NULL
%	NULL
binding	NULL
buffer	NULL
(	NULL
40	NULL
%	NULL
glycerol	NULL
,	NULL
40	NULL
mM	NULL
Tris/HCl	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
100	NULL
mM	NULL
KCl	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
,	NULL
2	NULL
mM	NULL
DTT	NULL
,	NULL
0.1	NULL
%	NULL
NP-40	NULL
,	NULL
50	NULL
ug/ml	NULL
poly-	NULL
[	NULL
dI-dC	NULL
]	NULL
)	NULL
and	NULL
2	NULL
ul	NULL
(	NULL
10,000	NULL
cpm	NULL
)	NULL
probe	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
then	NULL
separated	NULL
on	NULL
6	NULL
%	NULL
gels	NULL
,	NULL
which	NULL
were	NULL
dried	NULL
and	NULL
autoradiographed	NULL
.	NULL

For	NULL
supershift	NULL
,	NULL
6	NULL
pl	NULL
cell	NULL
extract	NULL
was	NULL
mixed	NULL
with	NULL
2	NULL
Ll	NULL
antibody	NULL
before	NULL
adding	NULL
binding	NULL
buffer	NULL
and	NULL
probe	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
Western	NULL
blot	NULL
.	NULL

After	NULL
cytokine	NULL
stimulation	NULL
,	NULL
2	NULL
x	NULL
10°	NULL
cells	NULL
in	NULL
each	NULL
sample	NULL
were	NULL
lysed	NULL
in	NULL
200	NULL
pl	NULL
lysis	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
%	NULL
NP-40	NULL
,	NULL
1	NULL
mM	NULL
Na	NULL
;	NULL
VO	NULL
,	NULL
,	NULL
10	NULL
mM	NULL
NaF	NULL
,	NULL
2	NULL
mM	NULL
PMSF	NULL
,	NULL
10	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
20	NULL
ug/ml	NULL
aprotinin	NULL
,	NULL
0.5	NULL
mM	NULL
EDTA	NULL
)	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

After	NULL
preclearing	NULL
of	NULL
lysates	NULL
at	NULL
13,000	NULL
g	NULL
,	NULL
the	NULL
supernatants	NULL
were	NULL
incubated	NULL
with	NULL
5	NULL
Ll	NULL
antiserum	NULL
to	NULL
JAK1	NULL
or	NULL
JAK3	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

This	NULL
was	NULL
followed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
35	NULL
ul	NULL
of	NULL
a	NULL
50	NULL
%	NULL
suspension	NULL
of	NULL
protein	NULL
A	NULL
Sepharose	NULL
beads	NULL
for	NULL
another	NULL
hour	NULL
.	NULL

After	NULL
washing	NULL
of	NULL
the	NULL
beads	NULL
in	NULL
lysis	NULL
buffer	NULL
minus	NULL
EDTA	NULL
,	NULL
the	NULL
pellet	NULL
was	NULL
boiled	NULL
with	NULL
sample	NULL
buffer	NULL
and	NULL
separated	NULL
by	NULL
8	NULL
%	NULL
SDS-PAGE	NULL
.	NULL

Proteins	NULL
were	NULL
transferred	NULL
to	NULL
Immobilon-P	NULL
membranes	NULL
,	NULL
which	NULL
were	NULL
overlayed	NULL
with	NULL
1	NULL
ug/ml	NULL
antiphosphotyrosine	NULL
antibody	NULL
and	NULL
then	NULL
developed	NULL
with	NULL
an	NULL
ECL	NULL
protocol	NULL
as	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
Amersham	NULL
Corp.	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

Plasmid	NULL
construction	NULL
and	NULL
transient	NULL
transfections	NULL
.	NULL

JAK3	NULL
cDNA	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
the	NULL
pcDNA3	NULL
vector	NULL
.	NULL

IL-4	NULL
Stat	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
same	NULL
expression	NULL
vector	NULL
via	NULL
the	NULL
EcoRI	NULL
and	NULL
Xhol	NULL
sites	NULL
.	NULL

COS-7	NULL
cells	NULL
were	NULL
grown	NULL
to	NULL
60	NULL
%	NULL
confluency	NULL
in	NULL
100-mm	NULL
petri	NULL
dishes	NULL
.	NULL

Utilizing	NULL
the	NULL
Ca	NULL
,	NULL
(	NULL
PO	NULL
,	NULL
)	NULL
;	NULL
method	NULL
,	NULL
these	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
either	NULL
15	NULL
ug	NULL
empty	NULL
vector	NULL
,	NULL
5	NULL
ug	NULL
pcDNA3-IL4	NULL
Stat	NULL
,	NULL
10	NULL
ug	NULL
peDNA3-JAK3	NULL
,	NULL
or	NULL
both	NULL
pcDNA3-IL-4	NULL
Stat	NULL
and	NULL
pcDNA3-JAK3	NULL
.	NULL

Salmon	NULL
sperm	NULL
DNA	NULL
was	NULL
used	NULL
to	NULL
adjust	NULL
the	NULL
total	NULL
amount	NULL
of	NULL
DNA	NULL
in	NULL
each	NULL
dish	NULL
.	NULL

9	NULL
h	NULL
after	NULL
transfec-tion	NULL
,	NULL
unincorporated	NULL
DNA	NULL
was	NULL
washed	NULL
away	NULL
with	NULL
warm	NULL
Hank	NULL
's	NULL
solution	NULL
and	NULL
replaced	NULL
with	NULL
12	NULL
ml	NULL
fresh	NULL
DME	NULL
for	NULL
a	NULL
further	NULL
40-h	NULL
culture	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Results	NULL
BL-2	NULL
cells	NULL
contain	NULL
an	NULL
IL-4-inducible	NULL
factor	NULL
which	NULL
binds	NULL
to	NULL
a	NULL
GAS	NULL
sequence	NULL
which	NULL
appears	NULL
upstream	NULL
of	NULL
the	NULL
I	NULL
,	NULL
exon	NULL
.	NULL

BL-2	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
IL-4	NULL
for	NULL
time	NULL
periods	NULL
ranging	NULL
between	NULL
1	NULL
and	NULL
15	NULL
min	NULL
,	NULL
and	NULL
cellular	NULL
extracts	NULL
were	NULL
assayed	NULL
by	NULL
EMSA	NULL
utilizing	NULL
a	NULL
*P-labeled	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
base	NULL
pairs	NULL
-153	NULL
to	NULL
-138	NULL
(	NULL
S1	NULL
oligonucleotide	NULL
)	NULL
of	NULL
the	NULL
human	NULL
I	NULL
,	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
)	NULL
.	NULL

This	NULL
sequence	NULL
is	NULL
homologous	NULL
to	NULL
the	NULL
9-bp	NULL
palindromic	NULL
motif	NULL
of	NULL
the	NULL
Fc	NULL
,	NULL
R	NULL
,	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
)	NULL
,	NULL
which	NULL
binds	NULL
IL-4	NULL
NAF	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Whole	NULL
BL-2	NULL
cell	NULL
extracts	NULL
showed	NULL
rapid	NULL
induction	NULL
of	NULL
an	NULL
IL-4-inducible	NULL
factor	NULL
,	NULL
which	NULL
we	NULL
designated	NULL
IL4	NULL
NAF	NULL
according	NULL
to	NULL
the	NULL
nomenclature	NULL
of	NULL
Kotanides	NULL
and	NULL
Reich	NULL
~180	NULL
-170	NULL
=160	NULL
-150	NULL
~140	NULL
-130	NULL
~120	NULL
I	NULL
I	NULL
1	NULL
}	NULL
1	NULL
ACCAGCCTCACCTGACCCCCGCTGTTGCTCAATCGACTTCCCAAGAACAGAGAGAAAAGGGAACTTCCAGGGCG	NULL
-110	NULL
-100	NULL
-90	NULL
-80	NULL
=-10	NULL
-60	NULL
~50	NULL
I	NULL
I	NULL
1	NULL
1	NULL
I1	NULL
I	NULL
I	NULL
GCCCGGECCTCCTGGGGTTCCCACCCCATTTTTAGCTGAAAGCACTGAGGCAGAGCTCCCCCTACCCAGGCTCC	NULL
~30	NULL
~20	NULL
~10	NULL
0	NULL
1	NULL
1	NULL
1	NULL
i	NULL
f*	NULL
ACTGCCCGGCACAGAAATAACAACCACGGTTACTGATCATCTGGGAG	NULL
+1	NULL
S1	NULL
oligonucleotide	NULL
:	NULL
FoI	NULL
:	NULL
CD23b	NULL
:	NULL
IL6	NULL
APRE	NULL
:	NULL
(	NULL
12	NULL
)	NULL
IL-4	NULL
<	NULL
Simulus	NULL
:	NULL
[	NULL
|	NULL
2	NULL
[	NULL
C.	NULL
P	NULL
[	NULL
<	NULL
o	NULL
J	NULL
@	NULL
@	NULL
cc	NULL
isin	NULL
(	NULL
Q	NULL
rome	NULL
Competitor	NULL
motif	NULL
:	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
:	NULL
0	NULL
1	NULL
5	NULL
10	NULL
15	NULL
5	NULL
5	NULL
IL-4	NULL
NAF	NULL
--	NULL
»	NULL
Lane	NULL
:	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
,	NULL
lanes	NULL
2-5	NULL
)	NULL
.	NULL

No	NULL
shift	NULL
complex	NULL
was	NULL
seen	NULL
during	NULL
treatment	NULL
with	NULL
PMA	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
or	NULL
exposure	NULL
of	NULL
BL-2	NULL
cells	NULL
to	NULL
IL-2	NULL
,	NULL
IFN-y	NULL
,	NULL
or	NULL
insulin	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
IL-4-induced	NULL
complex	NULL
was	NULL
competed	NULL
with	NULL
excess	NULL
unlabeled	NULL
S1	NULL
oligonucleotide	NULL
,	NULL
but	NULL
not	NULL
unlabeled	NULL
S2	NULL
oligonucleotide	NULL
,	NULL
which	NULL
corresponds	NULL
to	NULL
the	NULL
region	NULL
immediately	NULL
adjacent	NULL
to	NULL
S1	NULL
(	NULL
base	NULL
pairs	NULL
-174	NULL
to	NULL
-152	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
,	NULL
lanes	NULL
7-9	NULL
)	NULL
.	NULL

While	NULL
another	NULL
GAS	NULL
sequence	NULL
,	NULL
the	NULL
IL-6	NULL
responsive	NULL
APRE	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
)	NULL
,	NULL
interfered	NULL
with	NULL
IL-4	NULL
NAF	NULL
binding	NULL
,	NULL
a	NULL
non-GAS	NULL
like	NULL
IL-6	NULL
response	NULL
element	NULL
in	NULL
the	NULL
c-jun	NULL
promoter	NULL
,	NULL
known	NULL
as	NULL
JRE-IL-6	NULL
,	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
IL-4	NULL
NAF	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
,	NULL
lanes	NULL
10	NULL
and	NULL
11	NULL
)	NULL
.	NULL

IL-6	NULL
by	NULL
itself	NULL
failed	NULL
,	NULL
however	NULL
,	NULL
to	NULL
induce	NULL
a	NULL
shift	NULL
complex	NULL
with	NULL
S1	NULL
in	NULL
BL-2	NULL
or	NULL
any	NULL
other	NULL
cell	NULL
type	NULL
(	NULL
not	NULL
O	NULL
S2	NULL
S1	NULL
JRE	NULL
APRE	NULL
5	NULL
5	NULL
5	NULL
5	NULL
-40	NULL
Figure	NULL
1	NULL
.	NULL

ILA	NULL
induces	NULL
an	NULL
activity	NULL
which	NULL
recognizes	NULL
a	NULL
GAS-like	NULL
sequence	NULL
upstream	NULL
of	NULL
the	NULL
human	NULL
I	NULL
,	NULL
promoter	NULL
in	NULL
BL-2	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
sequence	NULL
upstream	NULL
of	NULL
the	NULL
human	NULL
I	NULL
,	NULL
exon	NULL
,	NULL
including	NULL
the	NULL
site	NULL
used	NULL
for	NULL
conducting	NULL
EMSA	NULL
(	NULL
underlined	NULL
)	NULL
,	NULL
is	NULL
shown	NULL
.	NULL

Base	NULL
pairs	NULL
were	NULL
numbered	NULL
from	NULL
the	NULL
first	NULL
initiation	NULL
codon	NULL
1	NULL
backwards	NULL
.	NULL

Below	NULL
,	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
S1	NULL
oligonucleotide	NULL
is	NULL
compared	NULL
with	NULL
IL-4	NULL
response	NULL
elements	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
Fe	NULL
,	NULL
R	NULL
;	NULL
and	NULL
CD23b	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
IL-6	NULL
APRE	NULL
.	NULL

The	NULL
imperfect	NULL
palindromes	NULL
contained	NULL
in	NULL
these	NULL
sequences	NULL
are	NULL
underlined	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Autoradiogram	NULL
of	NULL
EMSA	NULL
conducted	NULL
with	NULL
the	NULL
S1	NULL
oligonucleotide	NULL
.	NULL

5	NULL
x	NULL
10°	NULL
BL-2	NULL
cells	NULL
were	NULL
mock	NULL
stimulated	NULL
(	NULL
control	NULL
[	NULL
Cont	NULL
.	NULL
]	NULL

)	NULL
or	NULL
stimulated	NULL
with	NULL
100	NULL
ng/ml	NULL
PMA	NULL
or	NULL
20	NULL
ng/ml	NULL
human	NULL
recombinant	NULL
IL-4	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
period	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
EMSA	NULL
was	NULL
done	NULL
as	NULL
described	NULL
in	NULL
Methods	NULL
.	NULL

The	NULL
IL-4-induced	NULL
binding	NULL
factor	NULL
,	NULL
designated	NULL
IL4	NULL
NAF	NULL
(	NULL
lanes	NULL
1-5	NULL
)	NULL
,	NULL
was	NULL
not	NULL
induced	NULL
by	NULL
PMA	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

IL-4	NULL
NAF	NULL
was	NULL
competed	NULL
for	NULL
by	NULL
a	NULL
100-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
S1	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
,	NULL
but	NULL
not	NULL
unlabeled	NULL
sequence	NULL
2	NULL
(	NULL
$	NULL
2	NULL
)	NULL
,	NULL
which	NULL
corresponds	NULL
to	NULL
base	NULL
pairs	NULL
-174	NULL
to	NULL
-152	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

While	NULL
an	NULL
E-26	NULL
specific-like	NULL
IL-6	NULL
response	NULL
element	NULL
in	NULL
the	NULL
junB	NULL
promoter	NULL
(	NULL
JRE	NULL
)	NULL
failed	NULL
to	NULL
compete	NULL
with	NULL
IL-4	NULL
NAF	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
,	NULL
the	NULL
GAS-like	NULL
IL-6	NULL
response	NULL
element	NULL
,	NULL
also	NULL
known	NULL
as	NULL
the	NULL
APRE	NULL
,	NULL
did	NULL
compete	NULL
for	NULL
binding	NULL
(	NULL
lane	NULL
717	NULL
)	NULL
.	NULL

IL-4	NULL
10	NULL
11	NULL
shown	NULL
)	NULL
.	NULL

IL-4	NULL
NAF	NULL
activity	NULL
was	NULL
also	NULL
induced	NULL
by	NULL
IL-4	NULL
in	NULL
EBV-transformed	NULL
B	NULL
cell	NULL
lines	NULL
which	NULL
also	NULL
undergo	NULL
germ-line	NULL
C	NULL
,	NULL
transcription	NULL
upon	NULL
IL-4	NULL
treatment	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Monoclonal	NULL
antibodies	NULL
to	NULL
CD40	NULL
,	NULL
a	NULL
receptor	NULL
known	NULL
to	NULL
enhance	NULL
IL-4-induced	NULL
germ	NULL
line	NULL
C.	NULL
transcription	NULL
,	NULL
did	NULL
not	NULL
activate	NULL
IL-4	NULL
NAF	NULL
activity	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

IL-4	NULL
NAF	NULL
is	NULL
a	NULL
tyrosine	NULL
phosphoprotein	NULL
which	NULL
translocates	NULL
from	NULL
the	NULL
cytosol	NULL
to	NULL
the	NULL
nucleus	NULL
of	NULL
BL-2	NULL
cells	NULL
.	NULL

IL-4	NULL
NAF	NULL
activity	NULL
was	NULL
induced	NULL
in	NULL
BL-2	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cyclohexamide	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
posttranslational	NULL
modification	NULL
of	NULL
a	NULL
preformed	NULL
factor	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
type	NULL
of	NULL
posttranslational	NULL
modification	NULL
was	NULL
determined	NULL
to	NULL
be	NULL
protein	NULL
tyrosine	NULL
phosphory-	NULL
Interleukin	NULL
4	NULL
Activates	NULL
a	NULL
Stat	NULL
Protein	NULL
which	NULL
Interacts	NULL
with	NULL
the	NULL
I	NULL
,	NULL
Promoter	NULL
909	NULL
A	NULL
J	NULL
U	NULL
S	NULL
IL-4	NULL
lok	NULL
:	NULL
on	NULL
+	NULL
+	NULL
+	NULL
c	NULL
2	NULL
|	NULL
4G10	NULL
:	NULL
+	NULL
IL-4	NULL
:	NULL
ee	NULL
Genistein	NULL
:	NULL
0	NULL
_	NULL
O	NULL
100	NULL
25	NULL
5	NULL
OKT3	NULL
:	NULL
~	NULL
=	NULL
=	NULL
+	NULL
PTP	NULL
1C	NULL
:	NULL
o	NULL
c	NULL
-	NULL
0+	NULL
+	NULL
+o	NULL
+	NULL
Vanadate	NULL
:	NULL
-	NULL
-	NULL
>	NULL
so	NULL
o	NULL
%	NULL
NaF	NULL
:	NULL
~	NULL
-	NULL
0-0	NULL
+	NULL
-	NULL
4	NULL
«	NULL
IL-4	NULL
NAF	NULL
#	NULL
#	NULL
»	NULL
IL-4	NULL
NAF	NULL
-	NULL
-	NULL
»	NULL
ip	NULL
.	NULL

ke	NULL
k4	NULL
3	NULL
a	NULL
IL-4	NULL
NAF	NULL
-	NULL
»	NULL
‘	NULL
“	NULL
a	NULL
#	NULL
.	NULL

``	NULL
#	NULL
'	NULL
ﬁ	NULL
m	NULL
o	NULL
y	NULL
#	NULL
¥	NULL
1	NULL
2	NULL
3	NULL
4	NULL
10	NULL
2	NULL
3	NULL
40500	NULL
6	NULL
Figure	NULL
2	NULL
.	NULL

IL-4	NULL
NAF	NULL
induction	NULL
and	NULL
binding	NULL
to	NULL
the	NULL
S1	NULL
oligonucleotide	NULL
is	NULL
dependent	NULL
on	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

5	NULL
x	NULL
10°	NULL
BL-2	NULL
cells	NULL
were	NULL
precultured	NULL
with	NULL
varying	NULL
amount	NULL
genistein	NULL
for	NULL
2	NULL
h	NULL
at	NULL
37°C	NULL
before	NULL
stimulation	NULL
with	NULL
20	NULL
ng/ml	NULL
IL-4	NULL
for	NULL
10	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Control	NULL
cultures	NULL
were	NULL
stimulated	NULL
with	NULL
IL-4	NULL
without	NULL
prior	NULL
genistein	NULL
exposure	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
were	NULL
used	NULL
for	NULL
conducting	NULL
EMSA	NULL
.	NULL

In	NULL
some	NULL
vials	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
extract	NULL
was	NULL
preincubated	NULL
with	NULL
1	NULL
ug	NULL
4G10	NULL
(	NULL
antiphosphotyrosine	NULL
)	NULL
,	NULL
or	NULL
1	NULL
ug	NULL
OKT	NULL
-3	NULL
(	NULL
isotype	NULL
control	NULL
)	NULL
,	NULL
before	NULL
addition	NULL
of	NULL
the	NULL
probe	NULL
.	NULL

In	NULL
another	NULL
set	NULL
of	NULL
vials	NULL
10	NULL
ug	NULL
of	NULL
extract	NULL
was	NULL
incubated	NULL
with	NULL
1	NULL
ug	NULL
PTP-1C	NULL
,	NULL
a	NULL
tyrosine	NULL
phosphatase	NULL
,	NULL
for	NULL
30	NULL
min	NULL
at	NULL
30°C	NULL
in	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
1	NULL
uM	NULL
Na	NULL
;	NULL
VO	NULL
,	NULL
,	NULL
a	NULL
tyrosine	NULL
phosphatase	NULL
inhibitor	NULL
,	NULL
or	NULL
10	NULL
uM	NULL
NaF	NULL
,	NULL
a	NULL
serine/threonine	NULL
phosphatase	NULL
inhibitor	NULL
.	NULL

(	NULL
A	NULL
)	NULL
EMSA	NULL
showing	NULL
inhibitory	NULL
effect	NULL
of	NULL
genistein	NULL
on	NULL
IL-4	NULL
NAF	NULL
induction	NULL
.	NULL

(	NULL
lane	NULL
1	NULL
)	NULL
Nonstimulated	NULL
control	NULL
(	NULL
Cont	NULL
.	NULL
)	NULL

;	NULL
(	NULL
lanes	NULL
2-5	NULL
)	NULL
IL-4	NULL
stimulation	NULL
after	NULL
preloading	NULL
with	NULL
genistein	NULL
at	NULL
the	NULL
indicated	NULL
dose	NULL
(	NULL
uM	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EMSA	NULL
showing	NULL
inhibitory	NULL
effect	NULL
of	NULL
antiphosphotyrosine	NULL
mAb	NULL
(	NULL
4GIO	NULL
)	NULL
on	NULL
IL4	NULL
NAF	NULL
binding	NULL
to	NULL
the	NULL
S1	NULL
oligonucleotide	NULL
.	NULL

(	NULL
lane	NULL
7	NULL
)	NULL
Nonstimulated	NULL
control	NULL
;	NULL
lanes	NULL
2-4	NULL
)	NULL
IL-4	NULL
stimulation	NULL
and	NULL
pretreatment	NULL
of	NULL
the	NULL
cell	NULL
extract	NULL
with	NULL
no	NULL
antibody	NULL
,	NULL
4G10	NULL
or	NULL
OKT3	NULL
.	NULL

(	NULL
C	NULL
)	NULL
EMSA	NULL
showing	NULL
inhibitory	NULL
effect	NULL
of	NULL
tyrosine	NULL
phosphatase	NULL
PTP-1C	NULL
on	NULL
the	NULL
binding	NULL
activity	NULL
of	NULL
IL-4	NULL
NAF	NULL
to	NULL
the	NULL
S1	NULL
oligonucleotide	NULL
.	NULL

(	NULL
lane	NULL
7	NULL
)	NULL
Nonstimulated	NULL
control	NULL
;	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
IL-4	NULL
stimulated	NULL
;	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
IL-4-stimulated	NULL
whole	NULL
cell	NULL
extracts	NULL
plus	NULL
PTP-1C	NULL
;	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
plus	NULL
both	NULL
PTP-1C	NULL
and	NULL
NaF	NULL
;	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
plus	NULL
both	NULL
PTP-1C	NULL
and	NULL
vanadate	NULL
;	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
plus	NULL
PTP-1C	NULL
and	NULL
both	NULL
vanadate	NULL
and	NULL
NaF	NULL
.	NULL

lation	NULL
based	NULL
on	NULL
the	NULL
following	NULL
observations	NULL
.	NULL

First	NULL
,	NULL
the	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
(	NULL
PTK	NULL
)	NULL
inhibitor	NULL
,	NULL
genistein	NULL
,	NULL
interfered	NULL
with	NULL
induction	NULL
of	NULL
IL-4	NULL
NAF	NULL
in	NULL
BL-2	NULL
cells	NULL
in	NULL
a	NULL
dose-dependent	NULL
fashion	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
)	NULL
.	NULL

Similar	NULL
observations	NULL
were	NULL
made	NULL
with	NULL
a	NULL
second	NULL
PTK	NULL
inhibitor	NULL
,	NULL
erbstatin	NULL
.	NULL

Second	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
IL-4	NULL
NAF	NULL
is	NULL
a	NULL
tyrosine	NULL
phosphoprotein	NULL
as	NULL
determined	NULL
by	NULL
prevention	NULL
of	NULL
a	NULL
shift	NULL
complex	NULL
when	NULL
cell	NULL
lysates	NULL
were	NULL
prior	NULL
incubated	NULL
with	NULL
antiphosphotyrosine	NULL
antibodies	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
supershift	NULL
induced	NULL
during	NULL
EMSA	NULL
with	NULL
4610	NULL
,	NULL
no	NULL
shift	NULL
was	NULL
seen	NULL
with	NULL
an	NULL
unrelated	NULL
monoclonal	NULL
antibody	NULL
(	NULL
OKT3	NULL
)	NULL
of	NULL
the	NULL
same	NULL
isotype	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Third	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
the	NULL
phospho-tyrosyl	NULL
residues	NULL
on	NULL
IL-4	NULL
NAF	NULL
are	NULL
required	NULL
for	NULL
DNA	NULL
binding	NULL
by	NULL
,	NULL
determining	NULL
the	NULL
effect	NULL
of	NULL
a	NULL
protein	NULL
tyrosine	NULL
phosphatase	NULL
,	NULL
PTP-1C	NULL
on	NULL
already	NULL
activated	NULL
IL-4	NULL
NAF	NULL
:	NULL
PTP-1C	NULL
abrogated	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
shift	NULL
complex	NULL
when	NULL
nuclear	NULL
extracts	NULL
were	NULL
exposed	NULL
to	NULL
this	NULL
enzyme	NULL
before	NULL
conducting	NULL
EMSA	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
C	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

To	NULL
insure	NULL
that	NULL
the	NULL
loss	NULL
of	NULL
DNA	NULL
binding	NULL
was	NULL
a	NULL
result	NULL
of	NULL
the	NULL
action	NULL
of	NULL
the	NULL
tyrosine	NULL
phosphatase	NULL
,	NULL
we	NULL
included	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
a	NULL
tyrosine	NULL
phosphatase	NULL
inhibitor	NULL
,	NULL
and	NULL
NaF	NULL
,	NULL
a	NULL
serine	NULL
threonine	NULL
phosphatase	NULL
inhibitor	NULL
,	NULL
with	NULL
the	NULL
reactions	NULL
.	NULL

While	NULL
sodium	NULL
orthovanadate	NULL
negated	NULL
the	NULL
effect	NULL
of	NULL
PTP-1C	NULL
on	NULL
IL-4	NULL
NAF	NULL
binding	NULL
,	NULL
NaF	NULL
did	NULL
not	NULL
exert	NULL
any	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
C	NULL
,	NULL
lanes	NULL
4-6	NULL
)	NULL
.	NULL

Since	NULL
IL-4	NULL
NAF	NULL
is	NULL
a	NULL
tyrosine	NULL
phosphoprotein	NULL
which	NULL
interacts	NULL
with	NULL
a	NULL
GAS	NULL
sequence	NULL
,	NULL
this	NULL
raised	NULL
the	NULL
possibility	NULL
that	NULL
this	NULL
factor	NULL
belongs	NULL
to	NULL
the	NULL
Stat	NULL
protein	NULL
family	NULL
.	NULL

These	NULL
factors	NULL
are	NULL
phosphoproteins	NULL
which	NULL
bind	NULL
with	NULL
varying	NULL
affinity	NULL
to	NULL
a	NULL
series	NULL
of	NULL
GAS	NULL
910	NULL
Fenghao	NULL
et	NULL
al	NULL
.	NULL

like	NULL
elements	NULL
and	NULL
are	NULL
known	NULL
to	NULL
communicate	NULL
information	NULL
from	NULL
several	NULL
cytokine	NULL
receptors	NULL
to	NULL
the	NULL
nucleus	NULL
after	NULL
homo-	NULL
or	NULL
hetero-dimerization	NULL
in	NULL
the	NULL
cytosol	NULL
(	NULL
16	NULL
)	NULL
.	NULL

To	NULL
test	NULL
if	NULL
similar	NULL
translocation	NULL
can	NULL
be	NULL
demonstrated	NULL
in	NULL
BL-2	NULL
cells	NULL
,	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
prepared	NULL
for	NULL
analysis	NULL
by	NULL
EMSA	NULL
.	NULL

The	NULL
results	NULL
,	NULL
which	NULL
are	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
show	NULL
that	NULL
while	NULL
IL-4	NULL
NAF	NULL
activity	NULL
was	NULL
rapidly	NULL
induced	NULL
in	NULL
both	NULL
the	NULL
cytosol	NULL
and	NULL
the	NULL
nucleus	NULL
,	NULL
the	NULL
increase	NULL
in	NULL
cytosolic	NULL
activity	NULL
(	NULL
1	NULL
min	NULL
)	NULL
preceded	NULL
the	NULL
major	NULL
increase	NULL
in	NULL
nuclear	NULL
activity	NULL
(	NULL
2	NULL
min	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

This	NULL
latency	NULL
is	NULL
compatible	NULL
with	NULL
activation	NULL
in	NULL
the	NULL
cytosol	NULL
,	NULL
followed	NULL
by	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

IL-4	NULL
induces	NULL
robust	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK3	NULL
in	NULL
BL-2	NULL
cells	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat	NULL
proteins	NULL
requires	NULL
the	NULL
participation	NULL
of	NULL
a	NULL
family	NULL
of	NULL
PTK	NULL
's	NULL
,	NULL
namely	NULL
the	NULL
JAK	NULL
's	NULL
(	NULL
17	NULL
)	NULL
.	NULL

It	NULL
would	NULL
appear	NULL
as	NULL
if	NULL
select	NULL
cytokine	NULL
receptors	NULL
use	NULL
specific	NULL
combinations	NULL
of	NULL
JAK	NULL
``	NULL
s	NULL
to	NULL
activate	NULL
one	NULL
or	NULL
more	NULL
Stat	NULL
proteins	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

It	NULL
has	NULL
recently	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
IL-4	NULL
receptor	NULL
in	NULL
T	NULL
lymphocytes	NULL
and	NULL
NK	NULL
cells	NULL
activate	NULL
JAK3	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

BL-2	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
IL-4	NULL
for	NULL
various	NULL
lengths	NULL
of	NULL
time	NULL
,	NULL
and	NULL
immunoprecipitation	NULL
performed	NULL
for	NULL
JAK1	NULL
and	NULL
JAK3	NULL
.	NULL

These	NULL
complexes	NULL
were	NULL
analyzed	NULL
by	NULL
antiphosphotyrosine	NULL
immu-noblotting	NULL
.	NULL

While	NULL
IL-4	NULL
induced	NULL
relatively	NULL
weak	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK1	NULL
in	NULL
BL-2	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
,	NULL
lanes	NULL
2-6	NULL
)	NULL
,	NULL
there	NULL
was	NULL
a	NULL
robust	NULL
activation	NULL
of	NULL
JAK3	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
B	NULL
,	NULL
lanes	NULL
2-6	NULL
)	NULL
.	NULL

IL-4-induced	NULL
JAK3	NULL
phosphorylation	NULL
was	NULL
suppressed	NULL
by	NULL
genistein	NULL
at	NULL
doses	NULL
>	NULL
25	NULL
uM	NULL
,	NULL
which	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
effect	NULL
of	NULL
this	NULL
Cytosol	NULL
Nucleus	NULL
I	NULL
U	NULL
I	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
:	NULL
0	NULL
.	NULL

To	NULL
2	NULL
3	NULL
5.10	NULL
0	NULL
1	NULL
.	NULL

2	NULL
35:10	NULL
1-4	NULL
Nar	NULL
-	NULL
-	NULL
>	NULL
»	NULL
--	NULL
Wo	NULL
won	NULL
wat	NULL
t	NULL
tg	NULL
w-	NULL
wad	NULL
tut	NULL
tb	NULL
Lane	NULL
:	NULL
1°	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
Figure	NULL
3	NULL
.	NULL

IL-4	NULL
NAF	NULL
activity	NULL
is	NULL
induced	NULL
in	NULL
both	NULL
the	NULL
cytosol	NULL
and	NULL
the	NULL
nucleus	NULL
by	NULL
IL-4	NULL
.	NULL

BL-2	NULL
cells	NULL
were	NULL
mock	NULL
treated	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
7	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
20	NULL
ng/ml	NULL
IL-4	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
periods	NULL
(	NULL
lanes	NULL
2-6	NULL
and	NULL
8-12	NULL
)	NULL
.	NULL

The	NULL
cytosolic	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Lactic	NULL
dehydrogenase	NULL
activity	NULL
was	NULL
checked	NULL
to	NULL
show	NULL
that	NULL
there	NULL
was	NULL
no	NULL
cytosolic	NULL
contamination	NULL
of	NULL
nuclear	NULL
extracts	NULL
.	NULL

10	NULL
ug	NULL
of	NULL
each	NULL
extract	NULL
was	NULL
examined	NULL
by	NULL
EMSA	NULL
utilizing	NULL
the	NULL
S1	NULL
oligonucleotide	NULL
as	NULL
probe	NULL
.	NULL

Notice	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
prominent	NULL
shift	NULL
band	NULL
in	NULL
the	NULL
cytosol	NULL
at	NULL
1	NULL
min	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
a	NULL
point	NULL
at	NULL
which	NULL
nuclear	NULL
activity	NULL
is	NULL
barely	NULL
noticeable	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

inhibitor	NULL
on	NULL
induction	NULL
of	NULL
IL-4	NULL
NAF	NULL
activity	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

PMA	NULL
failed	NULL
to	NULL
activate	NULL
JAK1	NULL
or	NULL
JAK3	NULL
in	NULL
BL-2	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
,	NULL
lane	NULL
7	NULL
;	NULL
Fig	NULL
.	NULL

4	NULL
B	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to-	NULL
IL-4	NULL
,	NULL
IL-6	NULL
induced	NULL
robust	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK1	NULL
but	NULL
not	NULL
JAK3	NULL
in	NULL
the	NULL
IL-6	NULL
responsive	NULL
B	NULL
cell	NULL
line	NULL
,	NULL
AF-10	NULL
(	NULL
Fig	NULL
.	NULL

4,4	NULL
and	NULL
B	NULL
,	NULL
lanes	NULL
8	NULL
and	NULL
9	NULL
)	NULL
.	NULL

IL-4	NULL
failed	NULL
to	NULL
induce	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK2	NULL
in	NULL
BL-2	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
with	NULL
the	NULL
data	NULL
in	NULL
Figs	NULL
.	NULL

2	NULL
and	NULL
3	NULL
,	NULL
the	NULL
findings	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
strongly	NULL
suggest	NULL
that	NULL
IL-4	NULL
NAF	NULL
is	NULL
a	NULL
Stat	NULL
protein	NULL
which	NULL
operates	NULL
downstream	NULL
of	NULL
JAK3	NULL
in	NULL
BL-2	NULL
cells	NULL
.	NULL

During	NULL
conducting	NULL
of	NULL
EMSA	NULL
,	NULL
antisera	NULL
to	NULL
Stat	NULL
!	NULL

(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
,	NULL
Stat2	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
and	NULL
Stat3	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
failed	NULL
to	NULL
block	NULL
the	NULL
shift	NULL
of	NULL
the	NULL
IL-4	NULL
NAF	NULL
complex	NULL
.	NULL
'	NULL

A	NULL
rabbit	NULL
antiserum	NULL
to	NULL
Stat6	NULL
did	NULL
,	NULL
however	NULL
,	NULL
block	NULL
the	NULL
formation	NULL
of	NULL
this	NULL
DNA-protein	NULL
complex	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
antiphosphotyrosine	NULL
immunoprecipitates	NULL
from	NULL
BL-2	NULL
cells	NULL
,	NULL
showed	NULL
induction	NULL
of	NULL
100-	NULL
and	NULL
130-kD	NULL
phosphoproteins	NULL
by	NULL
IL-4	NULL
on	NULL
antiphosphotyrosine	NULL
overlay	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

While	NULL
p130	NULL
likely	NULL
represents	NULL
activated	NULL
JAK3	NULL
,	NULL
p100	NULL
is	NULL
the	NULL
exact	NULL
molecular	NULL
weight	NULL
of	NULL
IL-4	NULL
Stat	NULL
,	NULL
also	NULL
known	NULL
as	NULL
Stat6	NULL
.	NULL

Transfection	NULL
of	NULL
JAK3	NULL
and	NULL
IL-4	NULL
Stat	NULL
into	NULL
COS-7	NULL
cells	NULL
induces	NULL
a	NULL
DNA	NULL
binding	NULL
activity	NULL
which	NULL
coelectrophoreses	NULL
with	NULL
IL-4	NULL
NAF	NULL
.	NULL

To	NULL
establish	NULL
that	NULL
JAK3	NULL
can	NULL
activate	NULL
IL-4	NULL
NAF	NULL
,	NULL
we	NULL
attempted	NULL
overexpression	NULL
of	NULL
JAK3	NULL
in	NULL
BL-2	NULL
cells	NULL
without	NULL
success	NULL
.	NULL

We	NULL
did	NULL
succeed	NULL
,	NULL
however	NULL
,	NULL
in	NULL
transfecting	NULL
COS-7	NULL
cells	NULL
with	NULL
JAK3	NULL
and	NULL
could	NULL
demonstrate	NULL
that	NULL
the	NULL
transfected	NULL
kinase	NULL
is	NULL
constitutively	NULL
tyrosine	NULL
phosphorylated	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

On	NULL
cotransfecting	NULL
JAK3	NULL
_	NULL
with	NULL
IL-4	NULL
Stat	NULL
,	NULL
we	NULL
were	NULL
able	NULL
to	NULL
show	NULL
by	NULL
EMSA	NULL
that	NULL
an	NULL
S1	NULL
oligonucleotide	NULL
binding	NULL
activity	NULL
is	NULL
generated	NULL
in	NULL
the	NULL
cytosol	NULL
of	NULL
COS-7	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
this	NULL
shift	NULL
complex	NULL
comigrated	NULL
with	NULL
IL-4	NULL
NAF	NULL
from	NULL
BL-2	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lanes	NULL
/	NULL
and	NULL
2	NULL
)	NULL
.	NULL

No	NULL
shift	NULL
complexes	NULL
were	NULL
induced	NULL
in	NULL
COS-7	NULL
cells	NULL
transfected	NULL
with	NULL
empty	NULL
vector	NULL
,	NULL
JAK3	NULL
cDNA	NULL
or	NULL
IL-4	NULL
Stat	NULL
cDNA	NULL
only	NULL
(	NULL
Fig	NULL
.	NULL

A	NULL
Cell	NULL
line	NULL
:	NULL
BL-2	NULL
AF-10	NULL
T.	NULL
1	NULL
f	NULL
1	NULL
€	NULL
<	NULL
Stimulus	NULL
:	NULL
8	NULL
[	NULL
IL-4	NULL
]	NULL
E	NULL
[	NULL
IL-6|	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
:	NULL
O	NULL
O	NULL
5	NULL
15	NULL
30	NULL
60	NULL
5	NULL
0	NULL
5	NULL
198	NULL
--	NULL
-116	NULL
-	NULL
y	NULL
``	NULL
®	NULL
-	NULL
#	NULL
-	NULL
JAK1	NULL
86	NULL
:	NULL
--	NULL
t	NULL
66	NULL
KD	NULL
.	NULL

30	NULL
Q4-	NULL
Lane	NULL
:	NULL
__	NULL
1	NULL
20	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
IP	NULL
:	NULL
NIS	NULL
I——	NULL
(	NULL
1JAK	NULL
'	NULL
I	NULL
o	NULL
|	NULL
B	NULL
Cell	NULL
line	NULL
:	NULL
BL-2	NULL
AF-10	NULL
i	NULL
<	NULL
Stimulus	NULL
:	NULL
é	NULL
IL-4	NULL
E	NULL
IL-6	NULL
=	NULL
z-	NULL
_-Time	NULL
(	NULL
min	NULL
)	NULL
:	NULL
0	NULL
0	NULL
5	NULL
15	NULL
30	NULL
60	NULL
5	NULL
0	NULL
5	NULL
198	NULL
--	NULL
;	NULL
116	NULL
-	NULL
&	NULL
&	NULL
&	NULL
-	NULL
-a-	NULL
JAK3	NULL
86	NULL
«	NULL
o	NULL
-	NULL
wss	NULL
66	NULL
--	NULL
o	NULL
-	NULL
-	NULL
PEF	NULL
*RE	NULL
C	NULL
‘	NULL
t	NULL
!	NULL

«	NULL
lik	NULL
«	NULL
»	NULL
«	NULL
4	NULL
30	NULL
Lane	NULL
:	NULL
__	NULL
1	NULL
2003	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
IP	NULL
;	NULL
_	NULL
NIS	NULL
L	NULL
--	NULL
--	NULL
-	NULL
aJAK3	NULL
--	NULL
--	NULL
--	NULL
Figure	NULL
4	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK1	NULL
and	NULL
JAK3	NULL
in	NULL
response	NULL
to	NULL
IL4	NULL
treatment	NULL
.	NULL

25	NULL
%	NULL
10°	NULL
BL-2	NULL
cells	NULL
and	NULL
AF-10	NULL
cells	NULL
were	NULL
mock	NULL
treated	NULL
(	NULL
control	NULL
[	NULL
Cont	NULL
.	NULL
]	NULL

)	NULL
or	NULL
stimulated	NULL
with	NULL
20	NULL
ng/ml	NULL
human	NULL
recombinant	NULL
IL-4	NULL
,	NULL
100	NULL
ng/ml	NULL
PMA	NULL
or	NULL
100	NULL
U/ml	NULL
human	NULL
recombinant	NULL
IL-6	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
period	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
precleared	NULL
by	NULL
centrifugation	NULL
at	NULL
13,000	NULL
g	NULL
for	NULL
10	NULL
min	NULL
and	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
either	NULL
5	NULL
Ll	NULL
anti-JAK1	NULL
or	NULL
5	NULL
ul	NULL
anti-JAK3	NULL
antibody	NULL
.	NULL

Proteins	NULL
were	NULL
separated	NULL
on	NULL
8	NULL
%	NULL
SDS-PAGE	NULL
and	NULL
the	NULL
phosphorylation	NULL
of	NULL
JAK	NULL
1	NULL
and	NULL
JAK3	NULL
assessed	NULL
by	NULL
antiphosphotyrosine	NULL
immunoblotting	NULL
as	NULL
described	NULL
in	NULL
Methods	NULL
.	NULL

AF-10	NULL
is	NULL
a	NULL
human	NULL
IgE	NULL
producing	NULL
myeloma	NULL
cell	NULL
line	NULL
which	NULL
responds	NULL
to	NULL
IL-6	NULL
treatment	NULL
with	NULL
increased	NULL
proliferation	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Antiphosphotyrosine	NULL
immunoblot	NULL
of	NULL
JAK1	NULL
immunoprecipitates	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Antiphosphotyrosine	NULL
immunoblot	NULL
of	NULL
JAK3	NULL
immunoprecipitates	NULL
.	NULL

IP	NULL
,	NULL
immunoprecipitation	NULL
;	NULL
NIS	NULL
,	NULL
nonimmune	NULL
serum	NULL
.	NULL

Interleukin	NULL
4	NULL
Activates	NULL
a	NULL
Stat	NULL
Protein	NULL
which	NULL
Interacts	NULL
with	NULL
the	NULL
I	NULL
.	NULL

Promoter	NULL
911	NULL
Cell	NULL
line	NULL
:	NULL
BL-2	NULL
8	NULL
Figure	NULL
5	NULL
.	NULL

Antibodies	NULL
to	NULL
~|	NULL
-	NULL
Stat6	NULL
,	NULL
but	NULL
not	NULL
Statl	NULL
and	NULL
Stimulus	NULL
:	NULL
0	NULL
IL-4	NULL
Stat3	NULL
,	NULL
interfere	NULL
with	NULL
the	NULL
[	NULL
O-	NULL
OI	NULL
Antibody	NULL
:	NULL
0	NULL
0	NULL
formation	NULL
of	NULL
the	NULL
IL-4	NULL
NAF	NULL
complex	NULL
in	NULL
BL-2	NULL
cells	NULL
.	NULL

5	NULL
X	NULL
10°	NULL
BL-2	NULL
cells	NULL
or	NULL
AF-10	NULL
cells	NULL
were	NULL
either	NULL
mock	NULL
stimulated	NULL
or	NULL
stimulated	NULL
with	NULL
20	NULL
ng/ml	NULL
IL-4	NULL
for	NULL
10	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
examined	NULL
by	NULL
EMSA	NULL
with	NULL
labeled	NULL
S1	NULL
as	NULL
described	NULL
.	NULL

2	NULL
ul	NULL
of	NULL
anti-Statl	NULL
(	NULL
STAT1	NULL
)	NULL
,	NULL
anti-Stat3	NULL
(	NULL
STAT3	NULL
)	NULL
,	NULL
anti-Stat6	NULL
(	NULL
STAT6	NULL
)	NULL
,	NULL
or	NULL
nonimmune	NULL
serum	NULL
(	NULL
NIS	NULL
)	NULL
were	NULL
used	NULL
together	NULL
with	NULL
6	NULL
ul	NULL
cellular	NULL
extract	NULL
to	NULL
attempt	NULL
supershift	NULL
or	NULL
block	NULL
the	NULL
protein-DNA	NULL
inter-action	NULL
.	NULL

Unstimulated	NULL
cells	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
;	NULL
IL-4-stimulated	NULL
cells	NULL
,	NULL
no	NULL
preincubation	NULL
with	NULL
antiserum	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
;	NULL
preincubation	NULL
with	NULL
anti-Stat6	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
;	NULL
preincubation	NULL
with	NULL
rabbit	NULL
nonimmune	NULL
serum	NULL
(	NULL
NZS	NULL
;	NULL
lane	NULL
4	NULL
)	NULL
;	NULL
preincubation	NULL
with	NULL
anti-Stat3	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
;	NULL
preincubation	NULL
with	NULL
anti-Statl	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
;	NULL
preincubation	NULL
with	NULL
control	NULL
(	NULL
OKT3	NULL
)	NULL
mAb	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

STAT6	NULL
NIS	NULL
STAT3	NULL
STAT1	NULL
OKT3	NULL
IL-4	NULL
NAF	NULL
-	NULL
»	NULL
u	NULL
“	NULL
u	NULL
“	NULL
B	NULL
t	NULL
is	NULL
b	NULL
b	NULL
H	NULL
b	NULL
Lane	NULL
:	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
Probe	NULL
:	NULL
S1	NULL
7	NULL
,	NULL
lanes	NULL
3-5	NULL
)	NULL
.	NULL

These	NULL
results	NULL
strongly	NULL
suggest	NULL
,	NULL
that	NULL
IL-4	NULL
Stat	NULL
is	NULL
activated	NULL
by	NULL
JAK3	NULL
,	NULL
whereupon	NULL
this	NULL
transcription	NULL
factor	NULL
binds	NULL
to	NULL
the	NULL
same	NULL
site	NULL
as	NULL
IL-4	NULL
NAF	NULL
.	NULL

Discussion	NULL
In	NULL
this	NULL
paper	NULL
we	NULL
show	NULL
that	NULL
IL-4	NULL
induces	NULL
a	NULL
tyrosine	NULL
phosphoprotein	NULL
,	NULL
IL-4	NULL
NAF	NULL
,	NULL
which	NULL
interacts	NULL
with	NULL
a	NULL
GAS	NULL
sequence	NULL
upstream	NULL
of	NULL
the	NULL
human	NULL
I	NULL
,	NULL
exon	NULL
.	NULL

IL-4	NULL
NAF	NULL
activity	NULL
increases	NULL
in	NULL
the	NULL
cytosol	NULL
before	NULL
appearing	NULL
in	NULL
the	NULL
nucleus	NULL
,	NULL
which	NULL
is	NULL
compatible	NULL
with	NULL
cyto-sol-to-nuclear	NULL
translocation	NULL
.	NULL

IL-4	NULL
NAF	NULL
is	NULL
identical	NULL
to	NULL
IL-4	NULL
Stat	NULL
,	NULL
IP	NULL
and	NULL
blot	NULL
:	NULL
anti-PY	NULL
Figure	NULL
6	NULL
.	NULL

IL-4	NULL
induced	NULL
protein	NULL
tyrosine	NULL
phos-	NULL
.	NULL

2	NULL
%	NULL
<	NULL
phorylation	NULL
of	NULL
130-	NULL
and	NULL
Stimulus	NULL
:	NULL
8	NULL
4	NULL
&	NULL
100-kD	NULL
proteins	NULL
in	NULL
hu-185	NULL
-	NULL
man	NULL
BL-2	NULL
cells	NULL
.	NULL

Cell	NULL
stimulation	NULL
and	NULL
immuno-ann	NULL
«	NULL
#	NULL
-p130	NULL
_	NULL
precipitation	NULL
procedures	NULL
110	NULL
~	NULL
«	NULL
-p100	NULL
were	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

82	NULL
--	NULL
4	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
that	NULL
o	NULL
5	NULL
ul	NULL
4G10	NULL
was	NULL
used	NULL
.	NULL

Prose	NULL
o-	NULL
@	NULL
«	NULL
-	NULL
teins	NULL
were	NULL
resolved	NULL
by	NULL
8	NULL
%	NULL
SDS-PAGE	NULL
and	NULL
antiphosphotyrosine	NULL
immunoblotting	NULL
performed	NULL
with	NULL
1	NULL
ug/ml	NULL
4G10	NULL
.	NULL

(	NULL
lane	NULL
1	NULL
)	NULL
nonstimulated	NULL
cells	NULL
;	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
IL-4-stimulated	NULL
cells	NULL
;	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
PMA-stimulated	NULL
cells	NULL
.	NULL

Notice	NULL
induction	NULL
of	NULL
p130	NULL
and	NULL
p100	NULL
by	NULL
IL-4	NULL
and	NULL
p55	NULL
by	NULL
PMA	NULL
.	NULL

53	NULL
-	NULL
“	NULL
pi	NULL
«	NULL
a-	NULL
p55	NULL
Lane	NULL
:	NULL
1	NULL
2	NULL
3	NULL
912	NULL
-	NULL
Fenghao	NULL
et	NULL
al	NULL
.	NULL

Figure	NULL
7	NULL
.	NULL

EMSA	NULL
comparing	NULL
induction	NULL
of	NULL
S1	NULL
bonding	NULL
activity	NULL
in	NULL
JAK3/IL-4	NULL
Stat	NULL
cotrans-B	NULL
wa	NULL
KA	NULL
Stat	NULL
fected	NULL
COS-7	NULL
cells	NULL
and	NULL
IL-4-treated	NULL
BL-2	NULL
cells	NULL
.	NULL

&	NULL
a	NULL
‘	NULL
ﬁWm	NULL
BL-2	NULL
cos-7	NULL
IL-4	NULL
stimulus	NULL
:	NULL
~	NULL
>	NULL
=	NULL
peDNA	NULL
vector	NULL
:	NULL
10	NULL
%	NULL
4	NULL
r	NULL
pcDNA	NULL
IL-4	NULL
Stat	NULL
:	NULL
R	NULL
14	NULL
toa	NULL
peDNA-JAK3	NULL
:	NULL
20k	NULL
.	NULL

l	NULL
t	NULL
o	NULL
%	NULL
IL-4	NULL
NAF	NULL
-	NULL
»	NULL
BL-2	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IL-4	NULL
for	NULL
10	NULL
min	NULL
and	NULL
whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

COS-7	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
empty	NULL
pcDNA3	NULL
vector	NULL
,	NULL
JAK3	NULL
cDNA	NULL
,	NULL
IL4	NULL
Stat	NULL
cDNA	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
JAK3	NULL
+	NULL
IL-4	NULL
Stat	NULL
.	NULL

Whole	NULL
cell	NULL
extract	NULL
was	NULL
prepared	NULL
as	NULL
described	NULL
for	NULL
BL-2	NULL
cells	NULL
.	NULL

Both	NULL
cellular	NULL
extracts	NULL
were	NULL
used	NULL
to	NULL
conduct	NULL
EMSA	NULL
with	NULL
labeled	NULL
$	NULL
1	NULL
oligonucleotide	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
.	NULL

Activated	NULL
IL-4	NULL
Stat	NULL
and	NULL
IL-4	NULL
NAF	NULL
comigrated	NULL
.	NULL

Lane	NULL
:	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
Stat	NULL
family	NULL
which	NULL
recognizes	NULL
the	NULL
same	NULL
GAS	NULL
after	NULL
activation	NULL
by	NULL
JAK3	NULL
in	NULL
a	NULL
cotransfected	NULL
COS-7	NULL
cell	NULL
line	NULL
.	NULL

Our	NULL
study	NULL
shows	NULL
that	NULL
the	NULL
IL-4	NULL
response	NULL
element	NULL
in	NULL
human	NULL
I	NULL
,	NULL
promoter	NULL
is	NULL
homologous	NULL
to	NULL
the	NULL
response	NULL
element	NULL
characterized	NULL
by	NULL
Kohler	NULL
and	NULL
Rieber	NULL
(	NULL
13	NULL
)	NULL
,	NULL
Kotanides	NULL
and	NULL
Reich	NULL
(	NULL
12	NULL
)	NULL
,	NULL
and	NULL
Schindler	NULL
et	NULL
al	NULL
.	NULL

(	NULL
14	NULL
)	NULL
.	NULL

Kohler	NULL
and	NULL
Rieber	NULL
identified	NULL
the	NULL
so-called	NULL
NF-IL4	NULL
which	NULL
interacts	NULL
with	NULL
a	NULL
9-bp	NULL
motif	NULL
(	NULL
5'-TTCTAAGAA-3	NULL
'	NULL
)	NULL
in	NULL
the	NULL
human	NULL
CD23b	NULL
gene	NULL
promoter	NULL
(	NULL
13	NULL
;	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
)	NULL
.	NULL

Kotanides	NULL
and	NULL
Reich	NULL
described	NULL
induction	NULL
of	NULL
IL-4	NULL
NAF	NULL
in	NULL
a	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
,	NULL
Thp-1	NULL
,	NULL
which	NULL
recognizes	NULL
a	NULL
GAS	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
human	NULL
Fce	NULL
,	NULL
R	NULL
,	NULL
gene	NULL
(	NULL
12	NULL
;	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
is	NULL
compatible	NULL
with	NULL
the	NULL
ability	NULL
of	NULL
Stat	NULL
proteins	NULL
to	NULL
display	NULL
varying	NULL
affinity	NULL
for	NULL
a	NULL
series	NULL
of	NULL
GAS-like	NULL
elements	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
that	NULL
the	NULL
IL-6-induced	NULL
GAS	NULL
response	NULL
element	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
a	NULL
;	NULL
-macroglobulin	NULL
gene	NULL
(	NULL
32	NULL
)	NULL
competes	NULL
for	NULL
binding	NULL
of	NULL
IL-4	NULL
NAF	NULL
to	NULL
the	NULL
S1	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
)	NULL
.	NULL

IL-6	NULL
failed	NULL
,	NULL
however	NULL
,	NULL
to	NULL
induce	NULL
a	NULL
mobility	NULL
shift	NULL
complex	NULL
with	NULL
the	NULL
S1	NULL
oligonucleotide	NULL
.	NULL

The	NULL
IL-4	NULL
NAF	NULL
motif	NULL
contains	NULL
an	NULL
inverted	NULL
GAA	NULL
repeat	NULL
on	NULL
opposite	NULL
strands	NULL
(	NULL
12	NULL
)	NULL
,	NULL
similar	NULL
to	NULL
other	NULL
IL-4	NULL
response	NULL
elements	NULL
in	NULL
the	NULL
Fc.Ry	NULL
,	NULL
(	NULL
34	NULL
)	NULL
,	NULL
human	NULL
Fc.Rp	NULL
,	NULL
(	NULL
35	NULL
)	NULL
,	NULL
murine	NULL
C,1	NULL
(	NULL
36	NULL
)	NULL
,	NULL
murine	NULL
C	NULL
,	NULL
(	NULL
37	NULL
)	NULL
,	NULL
murine	NULL
MHCIIE/	NULL
#	NULL
(	NULL
38	NULL
)	NULL
,	NULL
human	NULL
MHCII-DRa	NULL
(	NULL
38	NULL
)	NULL
,	NULL
and	NULL
human	NULL
Fc	NULL
,	NULL
R	NULL
,	NULL
genes	NULL
(	NULL
38	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
)	NULL
.	NULL

Schindler	NULL
et	NULL
al	NULL
.	NULL

identified	NULL
the	NULL
so-called	NULL
signal	NULL
transducing	NULL
factor	NULL
for	NULL
IL-4	NULL
(	NULL
STF-IL4	NULL
)	NULL
which	NULL
interacts	NULL
with	NULL
a	NULL
GAS	NULL
sequence	NULL
in	NULL
the	NULL
IRF-1	NULL
gene	NULL
promoter	NULL
as	NULL
well	NULL
as	NULL
an	NULL
upstream	NULL
element	NULL
(	NULL
R1/R2	NULL
se-quence	NULL
)	NULL
in	NULL
the	NULL
murine	NULL
I.	NULL
promoter	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
R1/	NULL
R2	NULL
nucleotide	NULL
does	NULL
not	NULL
contain	NULL
the	NULL
inverted	NULL
GAA	NULL
repeat	NULL
.	NULL

IL-4	NULL
NAF	NULL
requires	NULL
to	NULL
be	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
resi-due	NULL
(	NULL
s	NULL
)	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
S1	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
)	NULL
.	NULL

Both	NULL
the	NULL
in	NULL
vitro	NULL
removal	NULL
of	NULL
phosphate	NULL
groups	NULL
from	NULL
tyrosine	NULL
residues	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
C	NULL
)	NULL
as	NULL
well	NULL
as	NULL
the	NULL
in	NULL
vivo	NULL
interference	NULL
with	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
)	NULL
abrogated	NULL
IL-4	NULL
NAF	NULL
activity	NULL
.	NULL

These	NULL
characteristics	NULL
,	NULL
together	NULL
with	NULL
the	NULL
feature	NULL
that	NULL
IL-4	NULL
NAF	NULL
is	NULL
activated	NULL
in	NULL
both	NULL
the	NULL
cytosol	NULL
and	NULL
nucleus	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
strongly	NULL
suggested	NULL
to	NULL
us	NULL
that	NULL
IL-4	NULL
NAF	NULL
is	NULL
a	NULL
Stat	NULL
protein	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
delay	NULL
by	NULL
which	NULL
nuclear	NULL
activity	NULL
is	NULL
induced	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
cytosolic	NULL
increase	NULL
suggests	NULL
intracellular	NULL
translocation	NULL
from	NULL
the	NULL
cytosol	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
which	NULL
is	NULL
another	NULL
characteristic	NULL
of	NULL
Stat	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Antibodies	NULL
to	NULL
Statl	NULL
,	NULL
Stat2	NULL
,	NULL
and	NULL
Stat3	NULL
failed	NULL
to	NULL
bind	NULL
to	NULL
IL-4	NULL
NAF	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Utilizing	NULL
the	NULL
identical	NULL
GAS	NULL
sequence	NULL
which	NULL
was	NULL
used	NULL
for	NULL
identifying	NULL
IL-4	NULL
NAF	NULL
,	NULL
Hou	NULL
et	NULL
al	NULL
.	NULL

recently	NULL
purified	NULL
and	NULL
cloned	NULL
the	NULL
gene	NULL
of	NULL
a	NULL
new	NULL
Stat	NULL
protein	NULL
,	NULL
which	NULL
was	NULL
designated	NULL
IL-4	NULL
Stat	NULL
,	NULL
also	NULL
known	NULL
as	NULL
Stat6	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Utilizing	NULL
an	NULL
antiserum	NULL
to	NULL
Stat6	NULL
,	NULL
we	NULL
were	NULL
able	NULL
to	NULL
show	NULL
that	NULL
the	NULL
IL-4	NULL
NAF	NULL
complex	NULL
could	NULL
be	NULL
supershifted/blocked	NULL
,	NULL
proving	NULL
that	NULL
IL-4	NULL
NAF	NULL
=	NULL
IL-4	NULL
Stat	NULL
=	NULL
Stat6	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
demonstrated	NULL
IL-4-induced	NULL
phosphorylation	NULL
of	NULL
a	NULL
100-kD	NULL
protein	NULL
in	NULL
BL-2	NULL
cells	NULL
,	NULL
which	NULL
is	NULL
the	NULL
identical	NULL
molecular	NULL
weight	NULL
of	NULL
IL-4	NULL
Stat	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Stat	NULL
protein	NULL
activation	NULL
involves	NULL
the	NULL
JAK	NULL
family	NULL
,	NULL
which	NULL
currently	NULL
consists	NULL
of	NULL
four	NULL
members	NULL
,	NULL
JAK1	NULL
,	NULL
JAK2	NULL
,	NULL
JAK3	NULL
,	NULL
and	NULL
Tyk2	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

It	NULL
would	NULL
appear	NULL
as	NULL
if	NULL
differential	NULL
association	NULL
of	NULL
one	NULL
or	NULL
more	NULL
of	NULL
these	NULL
kinases	NULL
with	NULL
the	NULL
activating	NULL
receptor	NULL
may	NULL
determine	NULL
which	NULL
Stat	NULL
proteins	NULL
are	NULL
activated	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
Stat1	NULL
activation	NULL
by	NULL
IFN-y	NULL
requires	NULL
both	NULL
JAK1	NULL
and	NULL
JAK2	NULL
to	NULL
activate	NULL
Stat1	NULL
,	NULL
while	NULL
Statl	NULL
and	NULL
Stat3	NULL
activation	NULL
by	NULL
the	NULL
IL-6	NULL
receptor	NULL
requires	NULL
JAK1	NULL
,	NULL
JAK2	NULL
,	NULL
and	NULL
Tyk2	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Recently	NULL
it	NULL
was	NULL
shown	NULL
that	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-7	NULL
,	NULL
and	NULL
IL-9	NULL
activate	NULL
JAK3	NULL
,	NULL
and	NULL
that	NULL
this	NULL
ability	NULL
is	NULL
dependent	NULL
on	NULL
their	NULL
sharing	NULL
of	NULL
a	NULL
common	NULL
signaling	NULL
subunit	NULL
,	NULL
C	NULL
,	NULL
,	NULL
which	NULL
is	NULL
physically	NULL
complexed	NULL
to	NULL
JAK3	NULL
(	NULL
23-27	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
IL-4	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK3	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
NK	NULL
cells	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

The	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK	NULL
's	NULL
is	NULL
indicative	NULL
of	NULL
their	NULL
activation	NULL
.	NULL

Simi-larly	NULL
,	NULL
in	NULL
BL-2	NULL
cells	NULL
we	NULL
found	NULL
robust	NULL
induction	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK3	NULL
by	NULL
IL-4	NULL
in	NULL
association	NULL
with	NULL
weak	NULL
JAK1	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
JAK1	NULL
associates	NULL
with	NULL
the	NULL
ligand-binding	NULL
140-kD	NULL
subunit	NULL
of	NULL
the	NULL
IL-4	NULL
receptor	NULL
and	NULL
contribute	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
JAK3	NULL
when	NULL
the	NULL
former	NULL
binds	NULL
to	NULL
C	NULL
,	NULL
.	NULL

Altogether	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
JAK3	NULL
is	NULL
the	NULL
PTK	NULL
which	NULL
is	NULL
directly	NULL
involved	NULL
in	NULL
activation	NULL
of	NULL
IL-4	NULL
NAF	NULL
.	NULL

To	NULL
prove	NULL
this	NULL
notion	NULL
more	NULL
directly	NULL
,	NULL
we	NULL
initially	NULL
attempted	NULL
to	NULL
overexpress	NULL
JAK3	NULL
in	NULL
BL-2	NULL
cells	NULL
,	NULL
but	NULL
did	NULL
not	NULL
succeed	NULL
.	NULL

As	NULL
an	NULL
alternative	NULL
,	NULL
we	NULL
cotransfected	NULL
JAK3	NULL
and	NULL
IL-4	NULL
Stat	NULL
cDNA	NULL
constructs	NULL
into	NULL
COS-7	NULL
cells	NULL
.	NULL

This	NULL
has	NULL
resulted	NULL
in	NULL
activation	NULL
of	NULL
a	NULL
cellular	NULL
protein	NULL
which	NULL
bound	NULL
the	NULL
S1	NULL
oligonucleotide	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
this	NULL
complex	NULL
comigrates	NULL
with	NULL
IL-4	NULL
NAF	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Because	NULL
this	NULL
complex	NULL
was	NULL
absent	NULL
from	NULL
cells	NULL
which	NULL
were	NULL
transfected	NULL
by	NULL
JAK3	NULL
or	NULL
IL-4	NULL
Stat	NULL
only	NULL
,	NULL
it	NULL
is	NULL
reasonable	NULL
to	NULL
assume	NULL
that	NULL
JAK3	NULL
actually	NULL
modified	NULL
the	NULL
cotransfected	NULL
IL-4	NULL
Stat	NULL
protein	NULL
.	NULL

The	NULL
exact	NULL
molecular	NULL
details	NULL
of	NULL
the	NULL
interaction	NULL
between	NULL
the	NULL
kinase	NULL
and	NULL
the	NULL
Stat	NULL
protein	NULL
and	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
IL-4	NULL
receptor	NULL
needs	NULL
to	NULL
be	NULL
further	NULL
studied	NULL
.	NULL

Insofar	NULL
as	NULL
germline	NULL
C	NULL
,	NULL
transcription	NULL
is	NULL
important	NULL
in	NULL
the	NULL
subsequent	NULL
event	NULL
of	NULL
IgE	NULL
gene	NULL
rearrangement	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
Stat6	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
IgE	NULL
production	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

Whether	NULL
binding	NULL
of	NULL
IL-4	NULL
NAF	NULL
to	NULL
the	NULL
I.	NULL
upstream	NULL
site	NULL
actually	NULL
leads	NULL
to	NULL
transcriptional	NULL
activation	NULL
is	NULL
unclear	NULL
.	NULL

Mutational	NULL
alteration	NULL
of	NULL
critical	NULL
base	NULL
pairs	NULL
in	NULL
the	NULL
9-bp	NULL
palindromic	NULL
motif	NULL
of	NULL
the	NULL
CD23	NULL
promoter	NULL
disrupted	NULL
IL-4-induced	NULL
activation	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
construct	NULL
(	NULL
13	NULL
)	NULL
.	NULL

When	NULL
the	NULL
sequence	NULL
upstream	NULL
of	NULL
the	NULL
I	NULL
,	NULL
promoter	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
was	NULL
linked	NULL
to	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
and	NULL
transfected	NULL
into	NULL
BL-2	NULL
cells	NULL
,	NULL
we	NULL
found	NULL
that	NULL
IL-4	NULL
alone	NULL
induced	NULL
weak	NULL
(	NULL
twofold	NULL
)	NULL
stimulation	NULL
of	NULL
luciferase	NULL
activity	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
relatively	NULL
weak	NULL
activation	NULL
of	NULL
a	NULL
related	NULL
luciferase	NULL
construct	NULL
transfected	NULL
into	NULL
DG75	NULL
and	NULL
BL-2	NULL
cells	NULL
by	NULL
Albrecht	NULL
et	NULL
al	NULL
.	NULL

(	NULL
39	NULL
)	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
anti-CD40	NULL
antibodies	NULL
,	NULL
however	NULL
,	NULL
we	NULL
found	NULL
that	NULL
IL-4	NULL
stimulated	NULL
a	NULL
definitive	NULL
increase	NULL
(	NULL
eightfold	NULL
)	NULL
in	NULL
luciferase	NULL
activity	NULL
in	NULL
transiently	NULL
transfected	NULL
BL-2	NULL
cells	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

CD40	NULL
is	NULL
known	NULL
to	NULL
deliver	NULL
a	NULL
signal	NULL
which	NULL
synergizes	NULL
with	NULL
the	NULL
IL-4	NULL
activation	NULL
pathway	NULL
in	NULL
human	NULL
B	NULL
lymphocytes	NULL
undergoing	NULL
C	NULL
,	NULL
.	NULL

rearrangement	NULL
(	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

CD40	NULL
ligation	NULL
failed	NULL
,	NULL
however	NULL
,	NULL
to	NULL
activate	NULL
IL-4	NULL
NAF	NULL
and	NULL
did	NULL
not	NULL
exert	NULL
additional	NULL
effects	NULL
on	NULL
IL-4	NULL
NAF	NULL
activation	NULL
by	NULL
IL-4	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
exact	NULL
role	NULL
of	NULL
IL-4	NULL
NAF	NULL
on	NULL
germline	NULL
transcription	NULL
needs	NULL
to	NULL
be	NULL
studied	NULL
further	NULL
.	NULL

Acknowledgments	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
U.S.	NULL
Public	NULL
Health	NULL
Service	NULL
,	NULL
grants	NULL
Al-15251	NULL
and	NULL
AI-34567	NULL
(	NULL
UCLA	NULL
Asthma	NULL
,	NULL
Allergy	NULL
and	NULL
Immunologic	NULL
Disease	NULL
Center	NULL
funded	NULL
by	NULL
the	NULL
National	NULL
Institute	NULL
of	NULL
Allergy	NULL
and	NULL
Infectious	NULL
Disease	NULL
and	NULL
the	NULL
National	NULL
Institute	NULL
of	NULL
Environmental	NULL
Health	NULL
Sciences	NULL
)	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Paul	NULL
,	NULL
W.	NULL
E.	NULL
1991	NULL
.	NULL

Interleukin	NULL
4	NULL
:	NULL
a	NULL
prototypic	NULL
immunoregulatory	NULL
lymphokine	NULL
.	NULL

Blood	NULL
.	NULL

77:1859-1870	NULL
.	NULL

2	NULL
.	NULL

Noelle	NULL
,	NULL
R.	NULL
,	NULL
P.	NULL
H.	NULL
Krammer	NULL
,	NULL
J.	NULL
Ohara	NULL
,	NULL
J.	NULL
W.	NULL
Uhr	NULL
,	NULL
and	NULL
E.	NULL
S.	NULL
Vitetta	NULL
.	NULL

1984	NULL
.	NULL

Increased	NULL
expression	NULL
of	NULL
Ta	NULL
antigens	NULL
on	NULL
resting	NULL
B	NULL
cells	NULL
:	NULL
an	NULL
additional	NULL
role	NULL
for	NULL
B-cell	NULL
growth	NULL
factor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

81:6149-6153	NULL
.	NULL

3	NULL
.	NULL

Conrad	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
T.	NULL
J.	NULL
Waldschmidt	NULL
,	NULL
W.	NULL
T.	NULL
Lee	NULL
,	NULL
M.	NULL
Rao	NULL
,	NULL
A.	NULL
D.	NULL
Keegan	NULL
,	NULL
R.	NULL
J.	NULL
Noelle	NULL
,	NULL
R.	NULL
G.	NULL
Lynch	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Kehry	NULL
.	NULL

1987	NULL
.	NULL

Effects	NULL
of	NULL
B	NULL
cell	NULL
stimulatory	NULL
factor-1	NULL
(	NULL
interleukin	NULL
4	NULL
)	NULL
on	NULL
Fc	NULL
,	NULL
and	NULL
Fc	NULL
,	NULL
receptor	NULL
expression	NULL
on	NULL
murine	NULL
B	NULL
lymphocytes	NULL
and	NULL
B	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

139:2290-2296	NULL
.	NULL

4	NULL
.	NULL

Vercell	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
R.	NULL
S.	NULL
Geha	NULL
.	NULL

1989	NULL
.	NULL

Regulation	NULL
of	NULL
IgE	NULL
synthesis	NULL
in	NULL
human	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Immunol	NULL
.	NULL

9:75-83	NULL
.	NULL

5	NULL
.	NULL

Gauchat	NULL
,	NULL
J.-F.	NULL
,	NULL
D.	NULL
A.	NULL
Lebman	NULL
,	NULL
R.	NULL
L.	NULL
Coffman	NULL
,	NULL
H.	NULL
Gascan	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
de	NULL
Vries	NULL
.	NULL

1990	NULL
.	NULL

Structure	NULL
and	NULL
expression	NULL
of	NULL
germline	NULL
e	NULL
transcripts	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
induced	NULL
by	NULL
interleukin	NULL
4	NULL
to	NULL
switch	NULL
to	NULL
IgE	NULL
production	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

172:463-473	NULL
.	NULL

6	NULL
.	NULL

Keegan	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
K.	NULL
Nelms	NULL
,	NULL
L.	NULL
M.	NULL
Wang	NULL
,	NULL
J.	NULL
H.	NULL
Pierce	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1994	NULL
.	NULL

IL-4	NULL
receptor	NULL
:	NULL
signaling	NULL
mechanisms	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
.	NULL

15:423-431	NULL
.	NULL

7	NULL
.	NULL

Keegan	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
K.	NULL
Nelms	NULL
,	NULL
W.	NULL
Morris	NULL
,	NULL
L.	NULL
M.	NULL
Wang	NULL
,	NULL
J.	NULL
H.	NULL
Pierce	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1994	NULL
.	NULL

An	NULL
IL-4	NULL
receptor	NULL
region	NULL
containing	NULL
an	NULL
insulin	NULL
receptor	NULL
motif	NULL
is	NULL
important	NULL
for	NULL
IL-4-mediated	NULL
IRS-1	NULL
phosphorylation	NULL
and	NULL
cell	NULL
growth	NULL
.	NULL

Cell	NULL
.	NULL

76:811-820	NULL
.	NULL

8	NULL
.	NULL

Izuhara	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
N.	NULL
Harada	NULL
.	NULL

1993	NULL
.	NULL

Interleukin-4	NULL
(	NULL
IL-4	NULL
)	NULL
induces	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
IL-4	NULL
receptor	NULL
and	NULL
association	NULL
of	NULL
phosphatidylinosi-tol	NULL
3-kinase	NULL
to	NULL
the	NULL
IL-4	NULL
receptor	NULL
in	NULL
a	NULL
mouse	NULL
T	NULL
cell	NULL
line	NULL
,	NULL
HT2	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:13097-13102	NULL
.	NULL

9	NULL
.	NULL

Skolnik	NULL
,	NULL
E.	NULL
Y.	NULL
,	NULL
C.	NULL
H.	NULL
Lee	NULL
,	NULL
A.	NULL
Batzer	NULL
,	NULL
L.	NULL
M.	NULL
Vicentini	NULL
,	NULL
M.	NULL
Zhou	NULL
,	NULL
R.	NULL
Daly	NULL
,	NULL
M.	NULL
J.	NULL
Myers	NULL
,	NULL
J.	NULL
M.	NULL
Backer	NULL
,	NULL
A.	NULL
Ullrich	NULL
,	NULL
M.	NULL
F.	NULL
White	NULL
,	NULL
and	NULL
J.	NULL
Schlessinger	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
SH2/SH3	NULL
domain-containing	NULL
protein	NULL
Grb2	NULL
interacts	NULL
with	NULL
tyrosine-phosphorylated	NULL
IRS1	NULL
and	NULL
Shc	NULL
:	NULL
implications	NULL
for	NULL
insulin	NULL
control	NULL
of	NULL
ras	NULL
signaling	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Org	NULL
.	NULL
)	NULL

J	NULL
.	NULL

12:1929-1936	NULL
.	NULL

10	NULL
.	NULL

Lebman	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
and	NULL
R.	NULL
L.	NULL
Coffman	NULL
.	NULL

1988	NULL
.	NULL

Interleukin	NULL
4	NULL
causes	NULL
isotype	NULL
switching	NULL
to	NULL
IgE	NULL
in	NULL
T	NULL
cell	NULL
stimulated	NULL
clonal	NULL
B	NULL
cell	NULL
culture	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

168:853-862	NULL
.	NULL

11	NULL
.	NULL

Lixing	NULL
,	NULL
X.	NULL
,	NULL
and	NULL
P.	NULL
Rothman	NULL
.	NULL

1994	NULL
.	NULL

IFN-y	NULL
represses	NULL
e	NULL
germline	NULL
transcription	NULL
and	NULL
subsequently	NULL
down-regulates	NULL
switch	NULL
recombination	NULL
to	NULL
e.	NULL
Int	NULL
.	NULL

Immunol	NULL
.	NULL

6:515-521	NULL
.	NULL

12	NULL
.	NULL

Kotanides	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
N.	NULL
C.	NULL
Reich	NULL
.	NULL

1993	NULL
.	NULL

Requirement	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
for	NULL
rapid	NULL
activation	NULL
of	NULL
a	NULL
DNA	NULL
binding	NULL
factor	NULL
by	NULL
IL-4	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

262:1265-1267	NULL
.	NULL

|	NULL
13	NULL
.	NULL

Kohler	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
E.	NULL
P.	NULL
Rieber	NULL
.	NULL

1993	NULL
.	NULL

Allergy-associated	NULL
Ie	NULL
and	NULL
Fce	NULL
receptor	NULL
II	NULL
(	NULL
CD23b	NULL
)	NULL
genes	NULL
activated	NULL
via	NULL
binding	NULL
of	NULL
an	NULL
interleukin-4-induced	NULL
transcription	NULL
factor	NULL
to	NULL
a	NULL
novel	NULL
responsive	NULL
element	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

23:3066-3071	NULL
.	NULL

14	NULL
.	NULL

Schindler	NULL
,	NULL
C.	NULL
,	NULL
H.	NULL
Kashleva	NULL
,	NULL
A.	NULL
Pernis	NULL
,	NULL
R.	NULL
Pine	NULL
,	NULL
and	NULL
P.	NULL
Rothman	NULL
.	NULL

1994	NULL
.	NULL

STF-IL-4	NULL
:	NULL
a	NULL
novel	NULL
IL-4	NULL
induced	NULL
signal	NULL
transducing	NULL
factor	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Org	NULL
.	NULL
)	NULL

J	NULL
.	NULL

13:1350-1356	NULL
.	NULL

15	NULL
.	NULL

Hou	NULL
,	NULL
J	NULL
.	NULL

Z.	NULL
,	NULL
U.	NULL
Schindler	NULL
,	NULL
W.	NULL
J.	NULL
Henzel	NULL
,	NULL
T.	NULL
C.	NULL
Ho	NULL
,	NULL
M.	NULL
Brasseur	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1994	NULL
.	NULL

An	NULL
interleukin-4-induced	NULL
transcription	NULL
factor	NULL
:	NULL
IL-4	NULL
Stat	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

265:1701-1706	NULL
.	NULL

16	NULL
.	NULL

Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
,	NULL
I.	NULL
M.	NULL
Kerr	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Stark	NULL
.	NULL

1994	NULL
.	NULL

Jak-STAT	NULL
pathways	NULL
and	NULL
transcriptional	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
IFNs	NULL
and	NULL
other	NULL
extracellular	NULL
signaling	NULL
proteins	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

264:1415-1421	NULL
.	NULL

17	NULL
.	NULL

Thie	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Witthuhn	NULL
,	NULL
F.	NULL
W.	NULL
Quelle	NULL
,	NULL
K.	NULL
Yamamoto	NULL
,	NULL
W.	NULL
E.	NULL
Thierfelder	NULL
,	NULL
B.	NULL
Kreider	NULL
,	NULL
and	NULL
O.	NULL
Silvennoinen	NULL
.	NULL

1994	NULL
.	NULL

Signaling	NULL
by	NULL
the	NULL
cytokine	NULL
receptor	NULL
super-family	NULL
:	NULL
JAKs	NULL
and	NULL
STATs	NULL
.	NULL

TZBS	NULL
(	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL
)	NULL

19:222-227	NULL
.	NULL

18	NULL
.	NULL

Fu	NULL
,	NULL
X.-Y	NULL
.	NULL

,	NULL
C.	NULL
Schindler	NULL
,	NULL
T.	NULL
Improta	NULL
,	NULL
R.	NULL
Aebersold	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Darnell	NULL
Jr.	NULL
1992	NULL
.	NULL

The	NULL
proteins	NULL
of	NULL
ISGF-3	NULL
:	NULL
the	NULL
interferon	NULL
-induced	NULL
transcriptional	NULL
activator	NULL
,	NULL
define	NULL
a	NULL
gene	NULL
family	NULL
involved	NULL
in	NULL
signal	NULL
transduction	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

89:7840-7843	NULL
.	NULL

19	NULL
.	NULL

Akira	NULL
,	NULL
S.	NULL
,	NULL
Y.	NULL
Nishio	NULL
,	NULL
M.	NULL
Inoue	NULL
,	NULL
X.	NULL
J.	NULL
Wang	NULL
,	NULL
S.	NULL
Wei	NULL
,	NULL
T.	NULL
Matsusaka	NULL
,	NULL
K.	NULL
Yoshida	NULL
,	NULL
T.	NULL
Sudo	NULL
,	NULL
M.	NULL
Naruto	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1994	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
APRE	NULL
,	NULL
a	NULL
novel	NULL
IFN-stimulated	NULL
gene	NULL
factor	NULL
3	NULL
pQ1-related	NULL
transcription	NULL
factor	NULL
involved	NULL
in	NULL
the	NULL
gp130-mediated	NULL
signaling	NULL
pathway	NULL
.	NULL

Cell	NULL
.	NULL

77:63-71	NULL
.	NULL

20	NULL
.	NULL

Zhong	NULL
,	NULL
Z.	NULL
,	NULL
Z.	NULL
Wen	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Damell	NULL
,	NULL
Jr.	NULL
1994	NULL
.	NULL

Stat3	NULL
and	NULL
Stat4	NULL
:	NULL
members	NULL
of	NULL
the	NULL
family	NULL
of	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

91:4806-4810	NULL
.	NULL

21	NULL
.	NULL

Wakao	NULL
,	NULL
H.	NULL
,	NULL
F.	NULL
Gouilleux	NULL
,	NULL
and	NULL
B.	NULL
Groner	NULL
.	NULL

1994	NULL
.	NULL

Mammary	NULL
gland	NULL
factor	NULL
Interleukin	NULL
4	NULL
Activates	NULL
a	NULL
Stat	NULL
Protein	NULL
which	NULL
Interacts	NULL
with	NULL
the	NULL
I	NULL
,	NULL
Promoter	NULL
913	NULL
(	NULL
MGF	NULL
)	NULL
is	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
cytokine	NULL
regulated	NULL
transcription	NULL
factor	NULL
gene	NULL
family	NULL
and	NULL
confers	NULL
the	NULL
prolactin	NULL
response	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Org	NULL
.	NULL
)	NULL

J	NULL
.	NULL

13:2182-2192	NULL
.	NULL

22	NULL
.	NULL

Shuai	NULL
,	NULL
K.	NULL
1994	NULL
.	NULL

Interferon-activated	NULL
signal	NULL
transduction	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

6253-259	NULL
.	NULL

23	NULL
.	NULL

Johnston	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
M.	NULL
Kawamura	NULL
,	NULL
R.	NULL
A.	NULL
Kirken	NULL
,	NULL
Y.-Q	NULL
.	NULL

Chen	NULL
,	NULL
T.	NULL
B.	NULL
Blake	NULL
,	NULL
K.	NULL
Shibuya	NULL
,	NULL
J.	NULL
R.	NULL
Ortaldo	NULL
,	NULL
D.	NULL
W.	NULL
McVicar	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
O'Shea	NULL
.	NULL

1994	NULL
.	NULL

Phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
JAK-3	NULL
Janus	NULL
kinase	NULL
in	NULL
response	NULL
to	NULL
interleukin-2	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

370:151-153	NULL
.	NULL

24	NULL
.	NULL

Witthubhn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
O.	NULL
Silvennoinen	NULL
,	NULL
O.	NULL
Miura	NULL
,	NULL
K.	NULL
S.	NULL
Lai	NULL
,	NULL
C.	NULL
Cwik	NULL
,	NULL
E.	NULL
T.	NULL
Liu	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Thie	NULL
.	NULL

1994	NULL
.	NULL

Involvement	NULL
of	NULL
the	NULL
Jak-3	NULL
Janus	NULL
kinase	NULL
in	NULL
signaling	NULL
by	NULL
interleukins	NULL
2	NULL
and	NULL
4	NULL
in	NULL
lymphoid	NULL
and	NULL
myeloid	NULL
cells	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

370:153-157	NULL
.	NULL

25	NULL
.	NULL

Russell	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
A.	NULL
D.	NULL
Keegan	NULL
,	NULL
N.	NULL
Harada	NULL
,	NULL
Y.	NULL
Nakamura	NULL
,	NULL
M.	NULL
Noguchi	NULL
,	NULL
P.	NULL
Leland	NULL
,	NULL
M.	NULL
C.	NULL
Friedmann	NULL
,	NULL
A.	NULL
Miyajima	NULL
,	NULL
R.	NULL
K.	NULL
Puri	NULL
,	NULL
W.	NULL
E.	NULL
Paul	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1993	NULL
.	NULL

Interleukin	NULL
2	NULL
receptor	NULL
y	NULL
chain	NULL
:	NULL
a	NULL
functional	NULL
component	NULL
of	NULL
the	NULL
interleukin-4	NULL
receptor	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

262:1880-1883	NULL
.	NULL

26	NULL
.	NULL

Russell	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Johnston	NULL
,	NULL
M.	NULL
Noguchi	NULL
,	NULL
M.	NULL
Kawamura	NULL
,	NULL
C.	NULL
M.	NULL
Bacon	NULL
,	NULL
M.	NULL
Friedmann	NULL
,	NULL
M.	NULL
Berg	NULL
,	NULL
D.	NULL
W.	NULL
McVicar	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Witthuhn	NULL
,	NULL
O.	NULL
Silvennoinen	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
.	NULL

Interaction	NULL
of	NULL
IL2RS	NULL
and	NULL
y	NULL
,	NULL
chains	NULL
with	NULL
Jak1	NULL
and	NULL
Jak3	NULL
:	NULL
implications	NULL
for	NULL
XSCID	NULL
and	NULL
XCID	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

266:1042-1045	NULL
.	NULL

27	NULL
.	NULL

Miyazaki	NULL
,	NULL
T.	NULL
,	NULL
A.	NULL
Kawahara	NULL
,	NULL
H.	NULL
Fujii	NULL
,	NULL
Y.	NULL
Nakagawa	NULL
,	NULL
Y.	NULL
Minami	NULL
,	NULL
Z.	NULL
J.	NULL
Liu	NULL
,	NULL
I.	NULL
Oishi	NULL
,	NULL
O.	NULL
Silvennoinen	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Witthuhn	NULL
,	NULL
J.	NULL
N.	NULL
Ihle	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1994	NULL
.	NULL

Functional	NULL
activation	NULL
of	NULL
Jak1	NULL
and	NULL
Jak3	NULL
by	NULL
selective	NULL
association	NULL
with	NULL
IL-2	NULL
receptor	NULL
subunits	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

266:1045-1047	NULL
.	NULL

28	NULL
.	NULL

Gauchat	NULL
,	NULL
J.-F.	NULL
,	NULL
H.	NULL
Gascan	NULL
,	NULL
R.	NULL
de	NULL
W.	NULL
Malefyt	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
de	NULL
Vries	NULL
.	NULL

1992	NULL
.	NULL

Regulation	NULL
of	NULL
germ-line	NULL
e	NULL
transcription	NULL
and	NULL
induction	NULL
of	NULL
e	NULL
switching	NULL
in	NULL
cloned	NULL
EBV-transformed	NULL
and	NULL
malignant	NULL
human	NULL
B	NULL
cell	NULL
lines	NULL
by	NULL
cytokines	NULL
and	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

148:2291-2299	NULL
.	NULL

29	NULL
.	NULL

Wegenka	NULL
,	NULL
U.	NULL
M.	NULL
,	NULL
C.	NULL
Liitticken	NULL
,	NULL
J.	NULL
Buschmann	NULL
,	NULL
J.	NULL
Yuan	NULL
,	NULL
F.	NULL
Lottspeich	NULL
,	NULL
W.	NULL
C.	NULL
Schindler	NULL
,	NULL
E.	NULL
Roeb	NULL
,	NULL
P.	NULL
C.	NULL
Heinrich	NULL
,	NULL
and	NULL
F.	NULL
Horn	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
interleukin-6-activated	NULL
acute-phase	NULL
response	NULL
factor	NULL
is	NULL
antigenically	NULL
and	NULL
functionally	NULL
related	NULL
to	NULL
members	NULL
of	NULL
the	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
(	NULL
STAT	NULL
)	NULL
family	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:3186-3196	NULL
.	NULL

30	NULL
.	NULL

Chodosh	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

1990	NULL
.	NULL

DNA-protein	NULL
interactions	NULL
.	NULL

In	NULL
Current	NULL
Protocols	NULL
in	NULL
Molecular	NULL
Biology	NULL
,	NULL
Vol	NULL
.	NULL

2	NULL
.	NULL

F.	NULL
M.	NULL
Ausubel	NULL
,	NULL
R.	NULL
Brent	NULL
,	NULL
R.	NULL
E.	NULL
Kingston	NULL
,	NULL
D.	NULL
D.	NULL
Moore	NULL
,	NULL
J.	NULL
G.	NULL
Seidman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Smith	NULL
,	NULL
and	NULL
K.	NULL
Struhl	NULL
,	NULL
editors	NULL
.	NULL

Greene	NULL
Publishing	NULL
Associates	NULL
and	NULL
Wiley-Interscience	NULL
.	NULL

John	NULL
Wiley	NULL
&	NULL
Sons	NULL
,	NULL
New	NULL
York	NULL
.	NULL

pp	NULL
.	NULL

12.1.1-12.1.9	NULL
.	NULL

914	NULL
Fenghao	NULL
et	NULL
al	NULL
.	NULL

31	NULL
.	NULL

Mills	NULL
,	NULL
F.	NULL
C.	NULL
,	NULL
J.	NULL
S.	NULL
Brooker	NULL
,	NULL
and	NULL
R.	NULL
D.	NULL
Camerini-Otero	NULL
.	NULL

1990	NULL
.	NULL

Sequences	NULL
of	NULL
human	NULL
immunoglobulin	NULL
switch	NULL
regions	NULL
:	NULL
implications	NULL
for	NULL
recombination	NULL
and	NULL
transcription	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18:7305-7316	NULL
.	NULL

32	NULL
.	NULL

Wegenka	NULL
,	NULL
U.	NULL
M.	NULL
,	NULL
J.	NULL
Buschmann	NULL
,	NULL
C.	NULL
Liitticken	NULL
,	NULL
P.	NULL
C.	NULL
Heinrich	NULL
,	NULL
and	NULL
F.	NULL
Horn	NULL
.	NULL

1993	NULL
.	NULL

Acute-phase	NULL
response	NULL
factor	NULL
,	NULL
a	NULL
nuclear	NULL
factor	NULL
binding	NULL
to	NULL
acute-phase	NULL
response	NULL
elements	NULL
,	NULL
is	NULL
rapidly	NULL
activated	NULL
by	NULL
interleukin-6	NULL
at	NULL
the	NULL
posttranslational	NULL
level	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:276-288	NULL
.	NULL

33	NULL
.	NULL

Nakajima	NULL
,	NULL
K.	NULL
,	NULL
T.	NULL
Kusafuka	NULL
,	NULL
T.	NULL
Takeda	NULL
,	NULL
Y.	NULL
FuJitani	NULL
,	NULL
K.	NULL
Nakae	NULL
,	NULL
and	NULL
T.	NULL
Hirano	NULL
.	NULL

1993	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
novel	NULL
interleukin-6	NULL
response	NULL
element	NULL
containing	NULL
an	NULL
Ets-binding	NULL
site	NULL
and	NULL
a	NULL
CRE-like	NULL
site	NULL
in	NULL
the	NULL
junB	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3027-3041	NULL
.	NULL

34	NULL
.	NULL

Suter	NULL
,	NULL
U.	NULL
,	NULL
G.	NULL
Texido	NULL
,	NULL
and	NULL
H.	NULL
Hofstetter	NULL
.	NULL

1989	NULL
.	NULL

Expression	NULL
of	NULL
human	NULL
lymphocyte	NULL
IgE	NULL
receptor	NULL
)	NULL
identification	NULL
of	NULL
the	NULL
Fc.R	NULL
,	NULL
,	NULL
,	NULL
promoter	NULL
and	NULL
its	NULL
functional	NULL
analysis	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

143:3087-3092	NULL
.	NULL

35	NULL
.	NULL

Yokota	NULL
,	NULL
A.	NULL
,	NULL
H.	NULL
Kikutani	NULL
,	NULL
T.	NULL
Tanaka	NULL
,	NULL
R.	NULL
Sato	NULL
,	NULL
E.	NULL
L.	NULL
Barsumian	NULL
,	NULL
M.	NULL
Suemura	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1988	NULL
.	NULL

Two	NULL
species	NULL
of	NULL
human	NULL
Fc	NULL
,	NULL
receptor	NULL
II	NULL
(	NULL
Fc	NULL
,	NULL
Ry/CD23	NULL
)	NULL
:	NULL
tissue-specific	NULL
and	NULL
IL-4-specific	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

Cell	NULL
.	NULL

55:611-618	NULL
.	NULL

36	NULL
.	NULL

Xu	NULL
,	NULL
M.	NULL
Z.	NULL
,	NULL
and	NULL
J.	NULL
Stavnezer	NULL
.	NULL

1992	NULL
.	NULL

Regulation	NULL
of	NULL
transcription	NULL
of	NULL
immunoglobulin	NULL
germ-line	NULL
y	NULL
1	NULL
RNA	NULL
:	NULL
analysis	NULL
of	NULL
the	NULL
promoter/enhancer	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Org	NULL
.	NULL
)	NULL

J	NULL
.	NULL

11:145-155	NULL
.	NULL

37	NULL
.	NULL

Rothman	NULL
,	NULL
P.	NULL
,	NULL
S.	NULL
C.	NULL
Li	NULL
,	NULL
B.	NULL
Gorham	NULL
,	NULL
L.	NULL
Glimcher	NULL
,	NULL
F.	NULL
Alt	NULL
,	NULL
and	NULL
M.	NULL
Boothby	NULL
.	NULL

1991	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
conserved	NULL
lipopolysaccharide-plus-interleukin-4-respon-sive	NULL
element	NULL
located	NULL
at	NULL
the	NULL
promoter	NULL
of	NULL
germ	NULL
line	NULL
e	NULL
transcripts	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:5551-5561	NULL
.	NULL

38	NULL
.	NULL

Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
and	NULL
C.	NULL
J.	NULL
Kara	NULL
.	NULL

1992	NULL
.	NULL

Sequences	NULL
and	NULL
factors	NULL
:	NULL
a	NULL
guide	NULL
to	NULL
MHC	NULL
class-HI	NULL
transcription	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

10:13-49	NULL
.	NULL

39	NULL
.	NULL

Albrecht	NULL
,	NULL
B.	NULL
,	NULL
S.	NULL
Peiritsch	NULL
,	NULL
and	NULL
M.	NULL
Woisetschlager	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
bifunctional	NULL
control	NULL
element	NULL
in	NULL
the	NULL
human	NULL
IgE	NULL
germline	NULL
promoter	NULL
involved	NULL
in	NULL
repression	NULL
and	NULL
IL-4	NULL
activation	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

6:1143-1151	NULL
.	NULL

40	NULL
.	NULL

Jabara	NULL
,	NULL
H.	NULL
H.	NULL
,	NULL
S.	NULL
M.	NULL
Fu	NULL
,	NULL
R.	NULL
S.	NULL
Geha	NULL
,	NULL
and	NULL
D.	NULL
Vercelli	NULL
.	NULL

1990	NULL
.	NULL

CD40	NULL
and	NULL
IgE	NULL
:	NULL
synergism	NULL
between	NULL
anti-CD40	NULL
monoclonal	NULL
antibody	NULL
and	NULL
interleukin	NULL
4	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
IgE	NULL
synthesis	NULL
by	NULL
highly	NULL
purified	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

172:1861-1864	NULL
.	NULL

41	NULL
.	NULL

Jumper	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Splawski	NULL
,	NULL
P.	NULL
E.	NULL
Lipsky	NULL
,	NULL
and	NULL
K.	NULL
Meek	NULL
.	NULL

1994	NULL
.	NULL

Ligation	NULL
of	NULL
CD40	NULL
induces	NULL
sterile	NULL
transcripts	NULL
of	NULL
multiple	NULL
IgH	NULL
chain	NULL
isotypes	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

152:438-445	NULL
.	NULL

